Open access

Current Challenges in the Treatment of Deep Sternal Wound Infection Following Cardiac Surgery

Written By

Martin Šimek, Martin Molitor, Martin Kaláb, Patrick Tobbia and Vladimír Lonsky

Submitted: July 9th, 2012 Published: March 13th, 2013

DOI: 10.5772/55310

Chapter metrics overview

3,114 Chapter Downloads

View Full Metrics

1. Introduction

Median sternotomy due to its technical simplicity and excellent exposure of the heart, great vessels and pulmonary hila is the most common incision performed in cardiothoracic surgery worldwide [1]. Originally described by Julian more than 100 years ago and re-induced by Milton in 1957, median sternotomy replaced gradually thoracotomy or bilateral transverse sternothoracotomy (clamshell incision) for routine access to the heart [2,3]. Even though median sternotomy is still considered to be the gold standard, efforts remain ongoing to use less invasive methods such as partial sternotomy or small thoracotomy to influence the risk of wound healing complications, patient’s satisfaction and better quality of life [4].


2. Incidence and risk factors of Deep Sternal Wound Infection (DSWI)

Infection involving the sternal bones and/or retrosternal space is a serious complication of median sternotomy. Although, DSWI can be described from many perspectives, the definition according to the Center for Disease Control and Prevention (CDC), is used for distinguishing DSWI from others types of sternal wound infections (SWIs), and is respected by most authors (Table 1) [5]. Looking through the incidence of DSWI ranging between 0.3 to 3.2%, no considerable changes have been observed in the incidence of DSWI over the last 30 years [6-22]. It could be perceived that the numerous advances in cardiac surgery, post-operative care and employment of preventive measurements may have played a role in reducing the incidence of DSWI in the last 10 years. Today surgically treated patients’ cohorts are different than patients operated on 20 years ago in terms of advanced age, co-morbidities, and surgical complexity. In other words, the relatively steady status of DSWI incidence over the last three decades might be considered a satisfactory result [23]. Recently Matros et al showed from a large single institution experience with 21,000 sternotomies a reduction in the incidence of DSWI from 1.57 to 0.88% in the last 15 years. They concluded that the rate of DSWI was significantly diminished particularly in the diabetic population, from 3.2% to 1.0%, related to tight glycemic control [19].

Diagnosis of DSWI requires at least one of the following criteria:
(1) anorganism is isolated from culture of mediastinal tissue or fluid
(2) evidence of mediastinitis is seen during operation or byhistopathological examination
(3) one of the following, fever("/>38º C), chest pain, or sternal instability, is present
and there is either purulent drainage from the mediastinum
or an organism isolated from blood culture or culture of drainage of the mediastinal area

Table 1.

Center for Disease Control and Prevention (CDC) criteria of DSWI (modified from Mangan et al[5])

The identification of risk factors for the development of DSWI is crucial in the effort to reduce the risk of infection [6-22]. Although more than two dozen factors were obtained for uni-, and multivariable analyses, only obesity and diabetes mellitus were constantly proven in published studies [6-18,21,22]. Obesity is a strong risk factor for development of DSWI. Even though BMI does not correlate closely with body fat, there is a step-wise relationship between BMI and the risk of major surgical infection in cardiac surgery [7,15,24]. It is caused not only through technical obesity-related problems, but also through less effective penetration of antibiotics into the fat tissue [24]. Undoubtedly, diabetics are at a higher risk of developing DSWI, making the role of perioperative glycemic control crucial. Unsatisfactory preoperative glycemic control is considered to be an important risk factor for development of DSWI [25,26]. Internal mammary artery (IMA) harvesting, particularly in the pedicled fashion, has been found to have a higher incidence of DSWI in a CABG cohort compared with valvular procedures [7,8]. Furthermore, this risk becomes stronger when both IMA are used for revascularization or in the diabetic population, but this effect might be attenuated when both IMA are taken down in a skeletonized fashion, even in diabetics [10,27,28]. Chronic obstructive pulmonary disease (COPD) or smoking increases the risk of infectious complications, prolonged post-operative ventilation, and jeopardizes sternal stability from excessive coughing [6,12,15]. Data addressing the impact of early tracheostomy on DSWI incidence is conflicting [29-31]. Historically, a strong relationship between early tracheostomy and DSWI has not been confirmed; but tracheostomy is known to reduce the need for mechanical ventilation and thereby may limit risk of pulmonary infection and ICU stay [32]. Furthermore, re-exploration for bleeding has been analyzed as an independent risk factor for DSWI in several studies [11,12]. The components of this risk factor include the risk of iatrogenic bacteriological wound contamination within the inherent re-exposure, the deleterious effect of anemia and/or concomitant hemodynamic instability, and the amount of given allogenic blood transfusion units [10,33]. Other factors traditionally associated with an increased risk of DSWI are inconsistently seen in analyses of retrospective studies including advanced age, emergency surgery, hemodynamic instability, low ejection fraction, duration of surgery and CPB time, and renal failure [6-22]. Incidence and risk factors based on multivariable analysis from larger retrospective studies are summarized in Table 2.

Authors Patients´ enrollement No. of patients DSWI incidence Independent risk factors
Loop FD et al [6] 1985-1987 6504 1.1% Obesity, BIMA+diabetes, time of operation,
Milano CA et al [7] 1987-1995 6459 1.3% Obesity, CHF, re-do surgery, CPB time
Braxton et al [8] 1992-1996 15406 1.25% Obesity, low EF, COPD
Eklund et al [9] 1990-1999 10713 1.1% Obesity, BMI
The Parisian Mediastinitis Study Group [10] 1996 1830 NA Obesity, BIMA, hemodynamic instability, re-do surgery
Hollenbeak et al [11] 1996-1998 1519 2.7% Obesity, renal inssuficieny, re-exploration
Filsouri et al [12] 1998-2005 5798 1.80% Obesity, MI, diabetes, COPD, CPB time, re-exploration, prolonged ventilation
Tang et al [13] 1990-2003 30102 0.77% Age, diabetes, stroke, CHF, BIMA+diabetes/CHF
Toumpoulis et al [14] 1992-2002 3760 1.1% Diabetes,dialysis, hemodynamic instability, BIMA
Risnes et al [15] 1989-2000 18532 0.6% Age, male gender, obesity, COPD, diabetes
Crabtree et al [16] 1996-2003 4004 2.2% Obesity, diabetes,"/>2 transfusion units
Fowler et al [17] 2002-2003 331429 NA Obesity, diabetes, MI, urgent surgery
Sjoegren et al [18] 1999-2004 4781 0.95% Diabetes, obesity, low EF, renal failure
Matros et al [19] 1991-2006 21000 1.35% Prolonged CPB time
De Feo et al [20] 1979-2009 22366 0.89% NA
Upton et al [21] 1998-2003 5176 1.2% Diabetes, urgent surgery, low EF
Sachithanandan et al [22] 2001-2005 4586 1.65% Diabetes, smoking, age, prolonged ventilation

Table 2.

Analyses of incidence and risk factors of DSWI

NA - not adrressed

BIMA - bilateral IMA harvesting

EF - ejection fraction

COPD - chronic obstructive pulmonary disease

CHF - congestive heart failure

MI - myocardial infaction


3. Microbiology of DSWI and routes of infection

Staphylococci, either S. aureus (SA) or coagulase-negative Staphylococcus (CONS) represent the most causative organism of DSWI, accounting for 60 to 80% of cases [34]. The proportion of individual strains of Staphylococcus and their methicillin-sensitivity varies between countries and institutions, reflecting their long-term hygienic and antibiotic policies [35]. Although surgical site infections are typically perceived to be an exogenous problem related to exposure to healthcare workers, the most causative pathogens are endogenous from patient’s own skin or mucosal flora [36,37]. Nasal carriage of SA has been identified as a potential risk factor for DSWI [38], and genetically identical SA from nasal flora have been cultivated from sternotomy wounds [39]. Unlike SA which caused a more aggressive presentation, CONS infection accompanied with bacteremia as observed in 50-60% of cases [34, 40] had a rather indolent course, clinically manifested later, and was more prone to recurrence [41, 42]. DSWI is diagnosed in 40-70% of patients post-discharge, thus post-discharge surveillance of up to 90 days is recommended [43]. Gram negative strains contribute less commonly in the pathogenesis of DSWI and mostly translocate from other host site infections, such as pneumonia, urinary or abdominal infections [34]. Finally, no significant difference in mortality was observed between DSWI infections caused by CoNS, when compared to SA, or Gram-negative pathogens [34]. Mekontso-Dessap et al suggested that DSWI caused by methicillin-resistant SA (MRSA) may have worse actuarial survival than sensitive strains (MSSA) in terms of 1 month, 1-year, and 3- year survival (60.0%±12.6%, 52.5%±-3.4%, and 26.3%±19.7% versus 84.6%±7.1%, 79.0%±8.6%, and 79.0%±-8.65, p=0.04), and a regression analysis revealed MRSA as an independent risk factor for overall mortality [44].


4. Outcomes and cost of DSWI

Unsurprisingly, DSWI negatively affected outcomes in cardiac surgery. Even with the adoption of modern treatment strategies, the reported in-hospital mortality for DSWI varies from 1.1 to 19% [6-9,11,16,45]. Although the mortality rate is similar to data reported from the 1980s, it appears that implementation of negative pressure wound therapy (NPWT) may improve long-term survival of patients [18,20,46]. Regardless of treatment strategy, in-hospital stay of DSWI patients is at least two weeks longer compared to patients with an uncomplicated post-operative course [6,10,11]. DSWI-related morbidity was repeatedly reported in relation to prolonged mechanical ventilation, renal impairment, atrial and ventricular arrhythmias, cerebrovascular accidents, need for hemodynamic support, and healing-related complications [20,47]. The cause of death in the early post-operative period is mostly multiple organ failure initiated by sepsis or specific DSWI-related complications such as serious bleeding [6-8,16,18,20]. Predictors of a poor outcome in DSWI patients that have been reported include length of intensive care unit (ICU) stay, late indication for surgical revision, bacteremia, hemodynamic instability, and prolonged mechanical ventilation [47,48]. Loop et al presented the worse survival data of DSWI in patients operated on during the 1980s in comparison with a standard CABG population within a 3-year follow-up after surgery [6]. Survival analyses published in the last decade consistently confirm long-term complications of patients with mid-, and long term survival rates who were successfully treated for DSWI (Table 3) [8,11,12,14,15,18,22,46]. Specific reasons for worsening of long-term survival are not yet clear. Risnes et al reported significantly higher cardiac-related deaths in the post-DSWI group (34.6 vs. 21.4%, p<0.006) and poorer survival for males ten years after surgery [15]. In contrast with this data, Sjoegren et al and Bailot et al showed unimpaired long-term survival of DSWI patients in comparison with patients who had uncomplicated surgery once NPWT was used [18,46].

Authors Patients´ enrollement Survival analysis
Loop FD et al [6] 1985-1987 3-year survival of 62.5% compared to 69.0% survival for patients with positive cultures. Overall, the 3-year survival was 75%, which is significantly below previously reported 5-year and even 10-year survival for isolated coronary bypass patients
Braxton et al [8] 1992-1996 The adjusted survival rates at 30 days, 1 year, and 4 years were 93%, 78%, and 65% among patients with mediastinitis and 97%, 95%, and 89% without mediastinitis, respectively (p<0.001)
Hollenbeak et al [11] 1996-1998 DSWI patient had a 1-year survival of 78% vs. 99% for non-infected CABG patients, p=0.0001
Filsouri et al [12] 1998-2005 Survival rates at 1,3, and 5 years were 72.4%, 64.3% and 55.8% for patients with DSWI compared with 93.8%, 88% and 82% for the control (p<0.001)
Toumpoulis et al [14] 1992-2002 Freedom from all cause mortality in patients in whom DSWI developed at 1 year, 5 years, and 10 years after the operation was 66.2%, 50.8%, and 40.6% respectively, compared with 87.2%, 72.8%, and 54.3% in patients without DSWI (p=0.0007)
Risnes et al [15] 1989-2000 The 10-year, long-term survival for patients with mediastinitis was 49.5%, compared with 71.0% in non-mediastinitis patients (p<0.01)
Sjoegren et al [18] 1999-2004 The actuarial survival at 1 year, 3 years, and 5 years was 92.9% , 89.2%, and 89.2% for patients with mediastinitis and 96.5%, 92.1%, and 86.9 for those without mediastinitis(p=0. 578)
Sachithanandan et al [22] 2001-2005 Unadjusted freedom from all-cause mortality in patients with DSWI at 1 year, 2 years, and 3 years after surgery was 78.6 ± 4.8% (95% CI 69–88.2%), 75.6 ± 5.0% (95% CI 65.6–85.6%) and 69.4 ± 5.8% (95% CI 57.8–81%) respectively compared with 92.8 ± −0.4% (95% CI 92.4–93.2%), 90.7 ± 0.5% (95% CI 90.2–91.2%) and 87.7 ± 0.6% (95% CI 87.1–88.3%) for patients without DSWI (p < 0.001)
Bailot et [46] 1992-2007 Survival in patients with DSWI showed freedom from all-cause mortality at 1, 5 and 10 years to be, respectively, 91.8%, 80.4% and 61.3% compared with 94.0%, 85.5% and 70.2%, respectively, for patients (p = 0.01). Adjusted survival for patients with DSWI treated with NPWT was 92.8%, 89.8% and 88.0%, respectively, at 1, 2 and 3 years, compared with 83.0%, 76.4% and 61.3%, respectively, for patients with DSWI treated conventionaly(p = 0.02)

Table 3.

Analyses of compared mid-term and long-term survival of patients with DSWI with non-DSWI patients

Patients who develop DSWI are 2.5 to 3 times more expensive to manage compared with patients who have an uncomplicated post-operative course [6,11]. The first calculation of cost originated from the Loop et al paper, published in the late 1980´s, and found a 2.8 times increase in cost [6]. Patients who died of DSWI consequences consumed 60,500 USD more, making the total cost of these patients approximately 80,000 USD compared with 11,000 USD an uncomplicated CABG patient cost, as showed by Hollenbeak et al [11]. Recent data from Germany showed a doubling in cost (36,261 vs. 13,356 EUR, p<0.001) for DSWI patients [49], while Ennker et al calculated a 9,000 EUR increase in cost on average for any DSWI case [50]. The majority of the increased cost is spent on repeat surgical and ICU service, and extension of in-hospital stay [11,51,52]. In looking for cost-effectiveness of treatment strategies, NPWT does not seem to be a more expensive treatment in comparison with the conventional therapy for DSWI, as calculated in the Swedish healthcare system by Mokhari et al [52]. Atkins et al reported lower NPWT costs than Medicare charges for conventional therapy (152,000 vs. 300,000 USD) of DSWI [53].


5. Strategies preventing DSWI

As mentioned previously, diabetes mellitus is a strong independent risk factor for development of DSWI, and concomitant obesity doubles the risk of further infection [24]. Unfortunately, both risk factors are difficult to modify. Zerr et al showed that a continuous insulin infusion started immediately after surgery to maintain a serum glucose level of 150-200mg/dl (8-11 mmol/l) led to a significant decrease in the incidence of DSWI in diabetics (2.4% to 1.5%, p < 0.02) compared with subcutaneously administered insulin [54]. A tight glycemic control protocol appears beneficial from the Portland group experience, nevertheless, decreasing serum glucose below 100mg/dl (6 mmol/l) did not bring any additional impact on DSWI rate, and was associated with a higher risk of stroke or death [55].

It has been demonstrated many times that antibiotic prophylaxis effectively prevents sternal wound infection [56]. As Staphylococcal stains are a major causative pathogen, beta-lactam antiobiotics are recommended for prophylaxis, particularly first or second generation cephalosporins [57]. The use of glycopeptides, which are highly effective against MRSA, has not been linked with a reduction in sternal wound infection rates compared to standard prophylaxis, with one study suggesting higher SSI´s rate (3.7 vs. 1.3%, p<0.05) when vancomycin prophylaxis was chosen [58]. Local application of a gentamicin soaked-collagen sponge between the sternal lamella was suggested to reduce all SWI´s, particularly DSWI. Friberg et al reported a significant reduction in SWI´s (3.7 vs. 9%, p<0.001), and also DSWI (1.5 vs. 3.3%, p<0.003) [59,60], however, further randomized controlled trials and meta-analyses did not confirm a benefit of using a gentamicin sponge for DSWI prevention as well as a recently published meta-analysis [61,62]. Although SA caused DSWI might be reduced by locally applied gentamicin, primarily gentamicin-resistant strains such a CONS may overgrow [62].

Another prophylactic issue is patient decontamination before surgery. As Staphylococci colonization is seen in a majority of DSWI, skin and nasopharyngeal decontamination became popular [38,39]. The use of chlorhexidine for skin care before surgery showed a significant reduction in the microbial count including SA [63]. In comparison to general surgery where reduction of SSI´s due to skin decontamination was confirmed [64], data for cardiac surgery is lacking, nevertheless, protocols involving chlorhexidine or a different skin cleanser are already widely accepted. Locally applied ointment containing mupirocin is 80 to 90% effective in eradicating all types of SA from the nasopharyngeal mucosa [65]. Cimochowski et al reported about the efficacy of this practice on reducing DSWI rates from 2.7% to 0.9% [66]. A randomized controlled trial published by Konvalinka et al did not confirm a reduced DSWI rate from the use of nasal mupirocin ointment (0.8 vs. 0.8%) [67].

The surgical technique in performing median sternotomy and its closure certainly influences the risk of DSWI. Careful handling of skin and pre-sternal soft tissue, mid-lined sternal incision and avoidance of bone wax are essential, in addition to keeping scrub protocol, checking for glove injury, changing gloves after sternotomy and after sternal wiring, and leaving the closed wound primarily covered for at least 48 hours [68].

It has been proposed that the method of IMA harvesting affects the incidence of DSWI, particularly when both IMA (BIMA´s) are demanded for revascularization [7,8,10,27,28]. A recent meta-analysis published by Saso et al showed a reduced risk of SWI´s once IMA or BIMA´s were harvested in a skeletonized fashion compared with a pedicled graft. The risk was reduced both in the non-diabetic (2.96% vs. 11.7%) and diabetic populations (2.4% vs. 14.2%) [69]. Besides harvesting methods of BIMA´s in diabetics, as was mentioned above, tight long-term glycemic control influenced the risk of DSWI. A hemoglobin A1c (HbA1c) ≥7% had a higher incidence of DSWI compared with patients who had a HbA1c <7% (5.0% vs. 1.4%, P = 0.014). A 31% increased risk of DSWI (OR = 1.31, 95% CI 1.16-1.49, P < 0.001) was seen by Halkos et al [26]. Even through diabetic patients may have a comparable risk of developing DSWI when IMA in skeletonized fashion is taken down, the BIMA´s harvesting need is to be considered carefully because additional risk factors such an obesity and COPD are commonly presented in this cohort [24,70].

The crucial point in preventing DSWI is achievement of stable sternal approximation. Standard sternal wire cerclage, if performed well, is fast, easy and effective [71]. Facing poor sternal quality, sternal fracture, or increased traction forces in obese or COPD patients, some modifications of this technique were proposed. Parasternal wire reinforcement, described originally by Robicsek and modified by Sharma, proved to reduce the risk of sternal wound complications [72,73]. Friberg et al reported that the use of more than 6 or 7 simple wires may also reduce DSWI rates (0.4% vs. 4.2%, p=0.001) [74]. Recently, a large multicenter prospective study conducted by Schimmer et al comparing the Robicsek technique with standard cerclage failed to reduce the risk of SWI and sternal dehiscence [75]. Primary plating, mirroring the experience in maxillofacial surgery, was proposed for patients at high risk of sternal non-union [76]. Plates could be anchored only into the sternal bone (SternaLock system™,Biomet Microfixation Inc, Jacksonville, US) or into the ribs (Titanium Sternal Fixation system™, Syntes, Switzeland). Raman et al reported better chest bone healing after primary plating than rewiring at 6-month follow up (70 vs. 24%, p=0.003) and lower pain scores, with no difference in SWI rates [77]. Others systems are used for sternal approximation including, thermoreactive nitinol clips (Flexigrip™, Praesidia SRL, Bologna, Italy), titanium locked staples (Sternal Talon™, KLS Martin Group, US), and Poly-Ether-Ether-Ketone tapes (Sternal ZipFix system™, Syntes, Switzeland), all designed for parasteral fixation. Negri et al reported a significant reduction of mechanical dehiscence (2.8% vs. 0.2%, p=0.002), but the same risk of DSWI (1.2% vs. 2.4%) when thermoactive clips were compared with standard wire cerclage [78]. Snyder et al reported 5 years of experience with the SternaLock system™ for primary plating in high risk patients. Superiority of plate over wires was seen in the incidence of early presentation (<30 days) of SWI (0% vs. 12%, p<0.06) and shorter in-hospital stay (7 vs. 8 days, p=0.02) [79]. A pilot study published by Bennett-Guerrero et al showed insignificantly higher spirometry volume in the SternalTalon™ arm (67% ± 32%) versus the wire arm (58% ± 24%). Use of the Talon was associated with decreased use of opiates (21.3 ± 11.8 vs. 25.4 ± 21.6 mg, P = 0.44), duration of mechanical ventilation (0.5 vs. 1.0 days, P = 0.24) and hospital length of stay (4.5 ± 3.2 vs. 5.3 ± 4.0 days, P = 0.40) [80].

A promising method to reduce SSI seems to be the application of NPWT on surgically closed sternal wounds. A commercially available system (Prevena® Incision Management System, KCI, St. Antonio, USA) is used, with skin preservation through a semipermeable membrane that has contact with foam, and one proposal pump system with reservoir is added [81]. Limited clinical experience has shown a decreased risk of wound hematoma, seroma and SSI [82]. Other positive effects from wound application of NPWT might include promotion of microvascular flow and decreased tissue edema and myofibroblast activation [83]. Colli and Atkins et al reported no wound healing complications in patients at high risk for sternal wound infections after cardiac surgery, but both studies were retrospective and done on smaller cohort of patients, 10 and 57, respectively [84,85].


6. Treatment strategies for DSWI

Even though treatment of DSWI has considerably evolved, a generally accepted treatment strategy remains controversial. Robicsek postulated three valid principles addressing this issue: first, that the infectious process should be brought under control within the shortest possible time, secondly, that adequate debridement and drainage of the infected area should occur, and third that sternal stability should be assured [86]. Until the 1960s, patients suffering from DSWI were treated conservatively with antibiotic therapy, limited drainage, or exposure of the sternotomy wound until closure with granulation tissue occurred [87]. Mortality rates then reached over 50% and survivors’ quality of life was limited due to significant morbidity [87]. In 1964, Shumacker and Mandelbaum reported their experience with single-stage technique of wound debridement, primary sternal re-wiring and continuous antibiotic irrigation [88]. Their original method was consequently modified in terms of the type of antibiotic or antiseptic solution used including its amount, or the setting of indwelling drains for irrigation and suction [89-90]. Closed chest drainage became widely used with reported mortality from DSWI ranging from 4.8% to 28%, with an associated risk of primary therapy failure ranging from 12.5% to 48% [89,90-92]. Lee et al proposed in 1976 the use of an omental flap for covering infected sternotomy wounds [93]. Vital greater omentum was turned into the chest cavity following sternal debridement. It was suggested that well-vascularized omentum fulfills dead spaces, ensures high antibiotic levels, and yielded angiogenic and absorptive capacity [13,93]. Jurkiewicz et al first reported the use of muscle flaps, preferably the pectoralis flap, and radical sternal debridement in the treatment of DSWI in 1980 [94]. Consequently, 20-years of experience in the Emory group with 409 patients showed 8.1% in-hospital mortality and 5.1% primary therapy failure. 87.1% of procedures were done in single-stage fashion; the pectoralis major was used in 76.6%, rectus abdominis in 19.4%, and omentum in 2.2% [95]. This approach has received many modifications regarding the timing of wound closure, choice of flap, and type of advancement, with reported mortality ranging from 0% to 19% [96,97]. Comparing the omental to the pectoralis flap, Milano et al reported that the omental flap had lower mortality (4.8% vs. 10.5%, p<0.05), early wound related complications (9.5% vs. 27.7%,p<0.001), and in-hospital stay (10.7 vs. 18.8%, p<0.05) [98]. El Oakley and Wright suggested classification of DSWI based on the time of presentation, presence of risk factors such as obesity, diabetes or immunosuppressive therapy, and number of failed therapeutic attempts in 1996 (Table 3) [99]. The identification of five subtypes of DSWI seemed to be a relevant tool for choice of therapeutic method and patient prognosis. Adjusted to the El Oakley and Wright classification, closed chest irrigation has comparable mortality data for type I and II DSWI compared with radical sternal resection and concomitant flap, but with lower flap-related associated morbidity [100-102]. Ringelman et al noted that at 48 month follow-up, 51% of patients had pain or discomfort, 44% had numbness, 42% complained of sternal instability, and 33% claimed to have shoulder weakness, when pectoral flap was used for reconstruction [103]. Closed chest irrigation carries a higher rate of therapy failure when used for type III, and particularly type IV and V El Oakley and Wright classification [104-107]. Thus, these patients might have benefit from more radical sternal debridement and employment of well-vascularized tissue to replenish residual defects. Flap-related morbidity may be addressed with less invasive techniques such as a laparoscopic greater omentum harvesting [108]. Atkins et al recently reported on the influence of sternal repair choice (pectoral, omental flap, or secondary closure) on long-term survival [109].

There is limited data evaluating hyperbaric oxygen (HBO) therapy in the treatment of SWI, despite theoretical advantages, availability of HTO close to the cardiac surgical unit impedes its routine use [110]. Siondalski et al reported successful healing of 55 DSWI patients with no mortality, nevertheless therapy required 20-40 HBO sessions after surgical revision. HTO was taken as an adjunct therapy to perform radical debridement and muscle flap [111].

Class Description of DSWI
Type I Mediastinitis presenting within 2 weeks after operation in the absence of risk factors
Type II Mediastinitis presenting at 2 to 6 weeks after operation in the absence of risk factors
Type IIIA Mediastinitis type I in the presence of one or more risk factors
Type IIIB Mediastinitis type II in the presence of one or more risk factors
Type IVA Mediastinitis type I, II, or III after one failed therapeutic trial
Type IVB Mediastinitis type I, II, or III after more than one failed therapeutic trial
Type V Mediastinitis presenting for the first time more than 6 weeks after operation

Table 4.

El Oakley and Wright classification of DSWI (modified from El Oakley et[99])

Accepted risk factors: diabetes, obesity, immunosupressive therapy intake

In 1997, Obdeijin et al described the first application of NPWT for treatment of DSWI in 3 consecutive patients [112]. They found that physical therapy contracted the wound, provided sufficient chest stability, and allowed patients to be extubated. Catarino et al reported the first retrospective comparison between NPWT and closed chest irrigation in 2000. In comparing 9 versus 10 patients, they found superiority of NPWT in length of in-hospital stay (15 vs. 40.5 days, p=0.02) and therapy failure (0 vs. 5, p=0.03) [113]. Furthermore, Gustafsson et al and Fleck et al, from the two most active European centers (Lund and Vienna), reported similar in-hospital and 30-day or 90-day mortality of DSWI patients, with 60% of all cases having class III according to El Oakley and Wright [114,115]. Consequently, the Lund group reported survival data from 1,3, and 5 year follow-up which showed comparable survival (92.9%, 89%, 89%) with patients without DSWI after CABG (96%,92%, 86%) and showed potential survival benefit of NPWT therapy unlike data known from conventional therapy [18]. Recently published data from a larger group of patients showed 1.1-5.4% mortality at 30 days and 8-15% 1 year mortality with a 2 to 6% risk of primary therapy failure [116-119]. The mean length of application of NPWT was 8 to 14 days with a mean number of 4 to 6 dressing changes [116-119]. The amount of dressing used by centers has only minor variability in first-line application protocol, with the only differences reported being the materials used for interface dressing and the timing of wound closure [116-119]. It was suggested that low C-reactive protein level (<50 mg/l) might be a good indicator for timing of wound closure [120]. Since the introduction of NPWT, its comparison with conventional therapy, closed chest irrigation or sternal resection and flap have been studied. So far, we have data only from retrospective comparative studies, with the compared arms being heterogeneous in number of patients, time periods and type of DSWI based on El Oakley classification. It was suggested that NPWT positively influenced the risk of primary therapy failure and survival of patients at short and long-term follow-up [18,46,121-138]. Outcomes of NPWT are DSWI causative pathogen independent, even comparing therapeutic response to MRSA and MSSA caused DSWI [139]. From multivariable analyses, obesity, renal failure and sepsis were calculated as independent risk factors of NPWT failure [128,129]. Results of comparative studies and published meta-analyses are shown in Table 5.

Authors Follow-up Patients´cohort Endpoints Results
Catarino et al [113] Retrospective 11 pts NPWT vs. 9 pts closed irrigation In-hospital stay, primary therapy failure NPWT linked with shorter in-hospital stay (15 vs. 40.5 days, p=0.02) and lower therapy failure (0 vs. 5%, p=0.03) than closed irrigation
Berg et al [121] Retrospective 31 pts NPWT vs. 29 pts closed irrigation Primary therapy failure, in-hospital stay and mortality NPWT group had a lower risk of therapy failure (52 vs. 16%, p<0.05) and in-hospital stay (22 vs. 26 days, p<0.05), with comparable in-hospital mortality (6,9 vs. 6,6%, NS) to closed irrigation
Doss et al [122] Retrospective 22 pts NPWT vs. 22 closed irrigation Primary therapy failure, in-hospital stay and mortality NPWT group had shorter overall length of therapy (17.2±5.8 vs. 22.9±10.8 days, p=0.01) and in-hospital stay (27.9±6.6 vs. 33.0±11.0 dnů, p=0.03), with comparable mortality (5 vs. 5%, NS) to closed irrigation
Song et al [123] Retrospective 17 pts NPWT vs. 18 pts open packing Primary therapy failure, number of dressing changes, in-hospital stay and mortality NPWT associated with shorter length of therapy ( 6.2 vs. 8.5 days, p<0,05), lower number of dresssing changes (3±2.5 vs. 17±8.6 , p<0.01), and comparable in-hospital mortality (11 vs. 6%, NS)
Luckraz et al [124] Retrospective 27 pts NPWT vs. 13 pts closed irrigation Primary therapy failure, in-hospital mortality, and cost of therapy NPWT linked with lower therapeutic failure rate (15 vs. 30.7%, p<0.05), in-hospital mortality (7.5% vs. 18.5%, p<0.05) and overall cost of therapy (16 400 vs. 20 000 USD) compared with closed irrigation
Fuchs et al [125] Retrospective 35 pts NPWT vs. 33 pts open packing Lenght to achieve sterile woud, length of therapy, in-hospital stay, and 1-year survival NPWT led to faster bacterial decontamination of wounds (16 vs. 26 days, p<0.01), shorter length of therapy (21 vs. 28 days, p<0.01) and in-hospital stay (25 vs. 34 days, p<0.01) and better 1-year survival (97.1 vs. 74.7%, p<0,05) compared with open packing
Sjoegren at el [126] Retrospective 61 pts NPWT vs. 40 closed irrigation/open packing Therapy failure, 1- and 5-year mortality NPWT had lower risk of therapy failure (0 vs.15%,p<0.01), 90 day mortality (0 vs. 15%, p<0,01), and 1- and 5-year survival (93 vs. 82%, 83 vs. 59%, p<0.05) against conventional therapy
Immer et al [127] Retrospective 38 pts NPWT vs. 17 sternectomy and flap In-hospital stay and in-hospital mortality, quality of life NPWT led to shorter in-hospital stay (51.5±20.8 vs. 70.7±28.8 dnů, p<0.05), non-significantly lower in-hospital mortality (5.3 vs 11.8, NS) and better quality of life based on questionnaire SF-36 compared with sternectomy and flap
Segers [128] Retrospective 29 pts NPWT vs. 34 pts closed irrigation Therapy failure, in-hospital, and 1-year mortality NPWT decreased primary therapy failure (27.6 vs. 58.9%, p<0.05), with comparable 30 day (3,5 vs. 2,9%, NS)and 1-year mortality (31.0 vs. 23.5%, NS) to closed irrigation
Bailot et al [46] Retrospektive conventional and prospective for NPWT 125 pts NPWT vs. 24 pts. open packing In-hospital mortality and 1-,5-, and 10 years survival Lower mortality in NPWT group (4.8 vs. 14.1%, p=0.01), but insignificantly better 1,5, and 10 year survival(92.8 vs. 83.0%, 89.8 vs. 76.4%, 88.0 vs. 61.3%, NS)
Petzina et al [129] Retrospective 69 pts NPWT vs. 49 closed irrigation Primary therapy failure, in-hospital stay and mortality NPWT associated with lower therapeutic failure (2.9% vs.18.3% p<0.05) and in-hospital mortality (5.8% vs. 24.5% p<0.05), but comparable in-hospital stay (38 vs. 41 days, NS) with closed irrigation
Simek et al [130] Retrospective for conventional and propective pro NPWT 38 pts withNPWT vs. 28 pts closed irrigation Primary therapy failure, in-hospital stay, in-hospital, and 1 year mortality NPWT had lower failure of primary therapy (5.8 vs. 39.2%, p<0.05), ICU stay (209.6±33.3 vs. 516.1±449.5 hours, p<0.01),and in-hospital (5.8 vs. 21.4%, p<0.05) and 1-year mortality (14.7 vs 39.2%, p<0.05), but comparable in-hospital stay (40.2±16.3 vs. 48.8±29.2, NS) with closed irrigation.
De Feo et al [131] Retrospective 74 pts NPWT vs. 83 pts closed irrigation Primary therapy failure, in-hospital stay and mortality NPWT group with lower risk of therapy failure (1.4 vs. 16.9%, p<0.001), shorter in-hospital stay (23.3±9 vs. 3.0.5±3, p<0,05), and lower in-hospital mortality (1.4 vs. 3,6 %, p<0,.05) compared with closed irrigation
Assman et al [132] Retrospective 82 pts NPWT vs. 38 closed irrigation In-hospital stay and mortality NPWT patients had shorter in-hospital stay (45.6 ± 18.5 vs. 55.2 ± 23.6 dnů, p<0.05), and lower in-hospital mortality (14.6 vs. 32.4 %, p<0.05)
Vos et al [133] Retrospective 89 pts NPWT vs. 24 open packing In-ICU and hospital stay and mortality NPWT led to shorter ICU stay (6.8±14.4 vs. 18.5±21.0 dnů, p<0.01), in-hospital stay (74.4±61.2 vs. 69.1±62.7 days, p<0.01), and lower in-hospital mortality (12.4 vs. 41.7%, p<0.01)
Deniz et al [134] Retrospective 47 pts NPWT vs. 43 pts closed irrigation Primary therapy failure, in-hospital stay and 1-, 3 years mortality NPWT had insignificantly lower rate of primary therapy failure (2.1% vs. 4.7%, NS) and shorter in-hospital stay (18±9 vs. 24±10 days, NS), 90 days mortality significantly lower (8.5 vs. 23.2%, p<0.05) and better 1-, and 3-year survival (91.5% vs.76.7%, p<0,05, 87.2 vs. 69.8%, P<0.05)
Fleck et al [135] Retrospective 326 pts NPWT vs. 198 closed irrigation/open packing Primary therapy failure, in-hospital mortality NPWT was associated with lower primary therapy failure (8.5% vs. 34% p<0.001), and in-hospital mortality (3.6% vs. 10%, p<0.05)
Sjoegren at el [18] Meta-analysis 12 papers focused on comparison of NPWT with conventional therapy Primary therapy failure, in-hospital stay and mortality NPWT associated with lower primary therapy failure, shorter in-hospital stay, and lower in-hospital and 1-year mortality
Raja et al [136] Meta-analysis 13 papers focused on comparison of NPWT with conventional therapy Primary therapy failure, in-hospital stay and mortality NPWT seemed to be effective at high-risk DSWI patients, but weak evidence for routine first-line application in DSWI
Schimmer et al [137] Meta-analysis 15 papers focused on comparison of NPWT with conventional therapy Primary therapy failure, in-hospital stay and mortality, evaluation of German hearts centers protocols NPWT is associated with lower therapeutic failure, and in-hospital mortality. Routinely applied as first-line treatment in 35% of German heart centers
Damiani G et al [138] Meta-analysis 6 papers focused on comparison of NPWT with conventional therapy and chest reconstruction options Primary therapy failure, in-hospital stay and mortality NPWT prone to have shorter in-hospital stay and lower mortality

Table 5.

Analyses and Meta-analyse of comparison NPWT with conventional therapy

Addressing specific complications of DSWI, it is seen that NPWT does not increase the risk of late infection recurrence. Reported rates of chronic fistulas after conventional therapy and NPWT were comparable between 8-12% [18,130,134,140,41], and long-term survival of these patients is negatively affected [140,142]. CONS was identified as a pathogen with a higher risk of recurrence; its low virulence, ability to create biofilm on metallic materials and inherent low sensitivity against prophylactically administrated antibiotics limit its eradication [41,143].

With the rise in use of NPWT came an increased number of reported serious bleeding complications [144,145]. The risk of heart injury, particularly the right ventricle, bypass grafts or great vessels is well known from conventionally treated patients. Infectious erosion, displacement of heart structures towards sternal margins, or tractions of fibrosis adhesion were identified as potential mechanism of injury [146]. The incidence of these complications by conventional therapy was found to be between 2-14.8% [147-149], with data from a larger group of NPWT treated patients showing 2 to 5%, thus NPWT does not seem to increase the incidence of serious complications [116,118,127,130,146,150]. Mortality from these complications varies between 25 to 70%, with emergency surgery as well as proper covering of mediastinal structures with interface dressing being crucial for management [146-148,150]. Several layers of paraffin gauze or silicone mesh are usually put below sternal margins on the heart and grafts. Development towards more suitable material, particularly rigid barrier for mediastinal protection is in progress, including mediastinal protection and preserved drainage ability of therapy [151].


7. Reconstruction of sternal bone defect after DSWI in cardiac surgery

Wire re-cerclage was a commonly used method for addressing sternal approximation in patients with sternal dehiscence after DSWI [72,86,102]. The quality of residual sternal bone or its loss makes re-cerclage troublesome or even risky for achieving sternal stability. The occurrence of extensive adhesions below the sternum in DSWI patients increases the risk of damage to the right ventricle and bypass grafts when peri-, trans- and parasternal wiring techniques are used [72,99,100]. Today, stable osteosynthesis of the sternum, particularly using transverse plates, has become a method of treatment of post-DSWI sternal dehiscence [76]. Voss at el reported an institutional experience with Titanium Sternal Fixation system™ plates for sternal non-union in 15 patients, in which four patients had more than two previous attempts to stabilize the chest with some modification of wire re-cerclage, and four patients were treated for DSWI with NPWT prior to plating. All patients were successfully stabilized and healed, with one patient from the DSWI group experiencing a late infection recurrence and one dying from a complication not related to plating [152]. Larger experience with the same plate system has been reported by Baillot et al in a group of 92 patients after DSWI [46]. They achieved chest stabilization in all cases, with 9 patients (9.8%) undergoing further procedure for late infection recurrence including removal of the plate with no impact on sternal stability [153]. Chest stability after a healed DSWI improves respiratory function, augments wound healing processes, shortens in-hospital stay, and improves patient quality [46,72,80]. Plating seems to be an effective method of chest wall stabilization, but may fail in cases of massive loss of chest bone tissue. In these cases, the bone residue does not allow sufficient anchoring for the plates or there is a large bone tissue gap. Shear forces may loosen screws and threaten stability. Persistent pain and respiratory discomfort were also reported in this case [154]. A conventional surgical approach to manage the large residual bone defect leaves the sternotomy wound unstable and employs the greater omentum or a muscle flap to fulfill any dead spaces [93,95,99,103]. This approach resulted in sternal instability and flap-related morbidity even when wounds were well-healed [154]. Some case reports have included the use of an autologous bone iliac crest graft or allogenous fibula graft to supply residual bone defects after DSWI [155,156]. Marulli reported the first use of an allogenous sternocostal bone graft for sternal reconstruction after chondrosarcoma removal [157]. Consequently, Dell'amore et al described four patients who were managed with the same technique with no wound healing complications and preserved chest wall stability [158]. The same authors proposed this technique for major post-DSWI defects, and [159] Kalab et al described the possibility of using an allogenous calva bone graft to address this issue. Allogenous bony grafts being fixed with transverse plates in mentioned cases [158-160]. Bone allograft usage for transplantation is under law restriction of local governments and European Association of Tissue Banks [161,162].


8. Options in soft tissue defects reconstruction after DSWI in cardiac surgery

There are a broad range of possibilities for managing sternal soft tissue defects caused by DSWI. In the case of minor defects, a direct suture with tissue undermining can be effective. In wide dehiscence, some type of flap transfer is needed and excessive bone and soft tissue loss are dependent on close co-operation between the cardiac and reconstructive surgeons. There are two crucial conditions influencing the reconstructive strategy. The first condition is the size of the defect, while the second is the vascular network, which would optimally remain uncompromised after primary surgery or previously failed reconstructions. Although various flaps and their modifications have been proposed, none have been found to be a reconstructive option for all defects [97,163,164], therefore Greig et al suggested a simple classification system to address the choice of flap based on the size and location of the post-sternotomy defect (Table 6) [165]. It is not possible, however, to follow this classification system because various factors and conditions influencing the result must be taken into the account.

Wound type Site of sternal wound Recommended flap for reconstruction
Type A Upper half sternum Pectoralis major
Type B Lower half sternum Combined pectoralis major and rectus abdominis bipedicled flap
Type C Whole sternum Combined pectoralis major and rectus abdominis bipedicled flap

Table 6.

Classification of sternal wounds according to anatomical site (modified from Greig et al [165])

In 1976, Lee et al were the first to report on the use of a pedicled greater omentum to fulfill the large defect after total sternectomy [93]. In 1980, Jurkiewicz et al introduced the bilateral pectoralis turnover flap for the same indication. Although various muscle flaps, along with their modifications have been reported, there is still debate about using muscular versus cutaneous or fasciocutaneous flaps to cover difficult defects. It has been presumed that muscular flaps carry richer vascular networks, thus bringing a better blood supply to the defect, along with a higher antibiotic concentration. Recent studies, however, did not support this hypothesis and suggested that muscle flaps have no particular advantage over fasciocutaneous flaps in terms of improving vascularity and eradicating infection [166,167]. Nevertheless, there is still a reasonable argument for muscular flaps as additional muscle brings enough tissue for planed reconstruction.

8.1. The pectoralis major flap

The pectoralis major provides many qualities that make it a suitable flap choice for covering sternal defects including close proximity to the sternotomy, triple blood supply (the thoracoacromial artery, perforating branches of the internal thoracic artery and the lateral thoracic artery), and versatility of the flap as either the thoracoacromial or internal thoracic artery vascular axis may be used separately to nourish the flap [168]. Netcher et al did not show an adverse influence of the pectoral muscle transposition on pulmonary function [169], moreover, pain and loss of strength appeared to be related more to sternal instability rather than to the muscle transposition. Additionally, Cohen et al reported an improvement of spirometric parameters (forced vital capacity and standardized forced expiratory volume in 1 second) before and after pectoral flap transfer, thus supporting the crucial role of the flap in chest stabilization [170].

8.1.1. Pectoral muscle advancement flap

The pectoral muscle advancement flap is based on the thoracoacromial pedicle and is considered to be the best muscular reconstructive option in this area due to its technical simplicity, versatility, and low risk of flap loss (<3%). There is, however, some risk of skin island necrosis or partial necrosis (≈30%) [171, 172]. Dissection and elevation of the flap begins along the median line of the costal grid until reaching the relatively avascular plane under the muscle. Undermining then proceeds by blunt dissection laterally as necessary to achieve approximation of the bilateral flaps at the median line without tension. The thoracoacromial vascular pedicle is visible at the dorsal plane of the muscle. The humeral and clavicular insertion of the muscle can be released if needed. If the distal portion of the sternum is exposed, dissection continues distally under the anterior sheet of the rectus abdominis which then becomes part of the flap [164]. Though the flap is elevated mostly in a myocutaneous fashion [73,163,164,173,174], Brutus et al reported on the use of a pectoral muscle flap released from skin for covering the entire sternal defect [175]. Completely dissected and freed from all of its origins, the pectoral muscle was advanced medially on the skeletonized vascular pedicle to cover the full length of the sternal defect. Separating the skin from the muscle can jeopardize the cutaneous blood supply and increase risk of skin necrosis. This technique included the release of humeral insertion from a short skin counter incision [175].

If the defect is wide, it may be difficult to achieve tension-free suturing in the midline. A modification of the advancement flap with a skin relaxing incision has been reported [176]. Majure et al proposed shifting the skin island over the pectoralis muscle in the V-Y manner to cover the entire sternotomy defect, but this method requires secondary skin grafting from an island donor site [177]. This technique was adopted and modified by Molitor et al [178]. The skin island is dissected, while the underlying muscle fascia and pectoralis major are elevated and completely released from their insertions to the humerus, sternocostal junctions and abdominal muscles. The thoracoacromial vessels are visualized and the clavicular insertion of the muscle is released to achieve comfortable advancement of the flap to the defect. The secondary defect in the lateral thoracic wall is then sutured in the V-Y manner and no skin graft is needed [178].

Finally, the pectoralis major musculocuteneous flap can be mobilized in a rotational manner when the skin-muscle flap is elevated based on the thoracoacromial pedicle and is rotated to the defect [179].

8.1.2. Pectoral muscle turnover flap

This flap is based on perforators of the internal mammary artery. Once the skin is elevated off of the anterior pectoralis fascia, the distal rib, proximal clavicular origin and humeral insertion of the muscle are divided. Then, the thoracoacromial pedicle is dissected and ligated, and the pectoralis major is elevated from lateral to medial until the perforating vessels from the internal thoracic artery are identified, and the muscle is then turned into the defect. To gain additional width of the narrowing humeral portion of the flap, fascial release incisions along the direction of the muscle fibers can be done. By this maneuver an average increase in flap width of 5.8 cm can be obtained [181]. Usually bilateral turnover muscle flaps are used [94,95]. The disadvantages of this flap include limitations in the distal parts of the sternum, need for wide skin undermining, dependence on an intact internal mammary artery, and an unfavorable aesthetic consequence including a missing anterior axillary line and parasternal subcutaneous tissue bulkiness [95].

8.2. The rectus abdominis flap

This flap was first used in cardiac surgery by Jurkiewicz in the case of a pectoral turnover flap failing to cover the entire defect [94,95]. To cover the sternal defect, the rectus abdominis flap is used exclusively as a pedicled flap based on the superior epigastric artery [182]. Because this artery is the terminal branch of the internal thoracic artery, the flap cannot be used if the ipsilateral internal thoracic artery was used for bypass grafting. The functional consequences of using the rectus abdominis to reconstruct sternal defects were assessed by Netscher et al [169]. They found no significant differences in abdominal wall function between the groups of patients in whom the rectus muscle was used for reconstruction and the group without sternal wound complications. There is a higher associated risk of hernia (11%) or fascial weakness (42%) as was reported [103,183]. The rectus abdominis flap may be used as a muscular flap [94,184) or as a myocutaneous island flap [171,185].

8.2.1. Rectus abdominis muscular flap

The rectus abdominis muscular flap may be dissected without the use of a skin island. The skin incision continues distally to the desired point according to the necessary flap length. The skin is undermined over the rectus fascia to expose the muscle. Then, the rectus anterior sheet is divided and the muscle is dissected and mobilized. The distal pedicle inferior epigastric vessels are ligated and divided. The muscle is then turned to the defect. The exposed muscle and pedicle is covered either by skin suture or grafting [95].

8.2.2. Rectus abdominis musculocutaneous flap

The myocutaneous flap can have a skin island oriented vertically along the used muscle (VRAM-vertical rectus abdominis muscle flap), or horizontally, as well as perpendicular to the muscle distal to the umbilicus (TRAM-transverse rectus abdominis muscle flap). The transverse orientation permits harvest of a larger skin paddle. Dissection of the VRAM starts with marking the skin island over the used muscle. The skin component should be placed medially near the umbilicus to include important periumbilical perforators. The skin island is cut and the skin overlying the muscle is undermined above the muscle fascia. Then, the rectus sheet is divided bilaterally at the edges of the muscle and the muscle is dissected and mobilized. The distal pedicle inferior epigastric vessels are ligated and divided. The flap is then turned to the defect. The TRAM is marked transversely under the umbilicus and skin island which can involve the entire area between the umbilicus and symphysis bilaterally. The flap is dissected in the similar way as the VRAM flap, but the mobilization of the skin island continues away from the muscle pedicle crossing the midline to the contralateral side [171,185]. Care must be taken to avoid pedicle compression passed through the subcutaneous tunnel to the sternal defect.

8.3. Combined pectoral muscle — Rectus abdominis muscle flap

For full length sternal defects, a combined pectoralis major and rectus abdominis flap (Pec-Rec flap) was proposed [186]. The flap is predominantly created on the left side, but can occasionally be bilateral. The skin overlying the pectoral muscle is elevated up to the mid-axillary line laterally and from the clavicle to the inferior costal line in a vertical direction. The pectoral muscle is elevated while preserving the thoracoacromial vessels. The muscle is detached from its humeral insertion and medially from one third of the clavicle. Dissection of the flap continues distally while elevating the thoracoepigastric fascial attachments from the chest wall between the pectoralis major and the rectus abdominis. Distal to the fascia, the anterior sheet of the rectus abdominis is incised medially and laterally and the muscle is mobilized from the posterior fascia. The muscular connections of the rectus abdominis to the distal ribs are detached as the last step of flap harvesting. The superior epigastric artery can be preserved or it can be divided close to the muscle if necessary for better medial transposition of the flap [186].

8.4. The latissimus dorsi muscle flap

The latissimus dorsi flap is based on a thoracodorsal artery that has not been jeopardized by previous cardiac surgery. Moreover, a large flap can be harvested (the main surface area of muscle is 105 cm2 for women and 192 cm2 for men) [187]. The main disadvantages of this flap include the need for a lateral decubital position during flap harvesting that can endanger patients with large sternal bone defect and sternal instability and shoulder functional limitation followed latissimus dorsi muscle harvesting. Patients who are dependent on their shoulder girdle strength, such as paralytic patients in a wheelchair or walker dependent patients, may endorse strength difficulties after muscle harvesting as well as tennis and golf players or those whose profession involves overhead tasks [187]. Up to 50% of patients may complain of localized numbness at the harvesting area [172].

Usually the muscle from the non-dominant side is used. The arc of rotation and position of the skin island is assessed and marked. The skin component is predominantly oriented perpendicular to the muscle fibers near the vertebral column, but a longitudinal course from the medial axillary line to the medial caudal dorsum is also possible. The flap is dissected using the whole muscle up to the pedicle. Thoracodorsal vessels are skeletonized and humeral muscle insertion is divided, allowing an additional 4-10 cm of flap advancement. Then the flap is transposed to the defect through a subcutaneous tunnel superficial to the pectoralis major [188,189].

8.5. Breast flap

Obese female patients with large breasts are at higher risk of sternal dehiscence due to the infero-lateral tension of the breasts, especially on the distal third of the sternotomy [72].This instability results from the greater protrusion of the lower thorax and abdomen during respiration, greater dimensions of the lower versus the upper thorax, the concentration of forces from the attachment of the ribs, and the reduced thickness of the lower sternum [72]. Therefore a special bandage, supporting bra, or other garment is used to release the tension resulting from large breasts. The technique of covering the sternal dehiscence with a bilateral pectoral muscle advancement flap with simultaneous breast reduction has been reported [190-192]. Large breasts carry an enormous amount of relatively well vascularized tissue that can potentially be used to cover the sternal defect [193,194]. The vascular supply of the breast is basically the same as the pectoral muscle. There is, however, a unique vascular network inside the breast gland, known as Würinger´s septum. Uygur et al reported a method of covering a large distal sternum defect with bilateral fasciocutaneous V-Y flaps from the breasts [193]. These flaps were anatomically based on the Würinger´s septum [193,195]. Another method has been suggested by Hamdi et al [196]. They performed a septum-based therapeutic mammoplasty on two patients. The principle of this technique is to reduce breast mass with harvesting of a large fasciocutaneous flap from the inferomedial part of the breast

Another possibility for utilizing the breasts to cover the sternal defect is a Cyclops´ flap. In this technique the whole breast is transposed to the central or even contralateral chest defect, so that the areola is centralized. The breast flap in this case is based on the lateral and central vascular pedicles of the breast [197,198].

8.6. Omentum

The greater omentum is a well-vascularized tissue with plentiful lymphatic drainage and angiogenic activity [93,98,199]. Its size can be up to 36x46 cm and is reliable to cover large defects. It is difficult, however, to predict the flap size preoperatively because the greater omentum volume has no direct correlation with the patient’s habitus [200]. The omentum can be transposed to the defect in various ways such as, pedicled on both gastroepiploic arteries for defects in the distal part of sternotomy wound or mobilized on either of the gastroepiploic vessels to cover full-length sternotomy defects [201-203]. Passing the omental flap subcutaneously from the upper portion of the laparotomy bears up to a 21% risk of late herniation [202], thus, a better solution seems to create the transdiaphragmatical tunnel just right of the falciform ligament [204]. The risk of abdominal cavity infection is rare [205], but the traction on the gastroepiploic artery can cause motility disturbances of the stomach and duodenum [206], and one case of fatal cecum volvulus have been reported [207]. Laparoscopic harvesting seems to be promising in reduction of access complications and pain [108,208,209].

8.7. Microsurgical flaps

Microsurgical free flaps can be used to cover sternal defects in particular situations. This technique, due to its duration and technical complexity, should serve as a last treatment option. The use of the tensor fascia lata myocutaneous flap, rectus abdominis myocutaneous flap and deep inferior epigastric artery fasciocutaneous flap for this indication have been reported [210]. As a donor vessel, the thoracoacromial, internal thoracic or cervical vessels can be used. The cephalic vein attached to the thoracoacromial or cervical arteries, can be used for lengthening the donor vessel (arterio-venous loop) [210,211].

8.8. Specifics of care after flap surgery in cardiac surgery

There are special requirements for care after flap surgery. In general, it is important to protect the blood circulation within the flap, maintaining both general and local hemodynamics. Vascular spasm must be prevented by using vasodilator drugs if possible. The elevated and transposed flap usually loses most of its physiological blood and lymphatic network and is dependent only on a small part of it, so varying degrees of edema are usually present. Large swelling of the tissue compresses the capillaries and decreases the blood flow in the flap, increasing the tension on the suture. Corticosteroids are used to prevent swelling for several days in most flap surgeries unless serious contraindications are present. The flap must be kept from topical pressure, particularly in places of passing vascular pedicle and in peripheral parts of the flap because of limited vascular competence. Undoubtedly, changes in body position influence the blood supply of the flap. Furthermore, stretching of the arms causes increased tension on the medial sternal suture. In the case of the pectoral and latissimus dorsi flap, the use of muscles of the shoulder girdle should be avoided. When using the rectus abdominis flap, the abdominal wall must be relaxed and supported with bandages for several weeks to prevent hernia formation. Finally, nutritional support with enteral feeding is essential for successful healing.


9. University hospital Olomouc management of DSWI after cardiac surgery

9.1. Adopted treatment strategy for DSWI

We retrospectively analyzed our experience with treatment strategies of DSWI since February 2002, when our department was established. A total of 100 patients fulfilling CDC criteria [5] for DSWI were enrolled until September 2011 with an overall incidence of DSWI of 1.36%. The results of 28 patients (March 2002-June 2004) primarily treated with closed chest irrigation using diluted iodine solution were compared with 76 patients (September 2004 to September 2009) treated with NPWT (VAC ATS™, KCI, St. Antonio, USA). A standardized protocol for first-line application of NPWT is depicted in Figure 1. Six patients from the interim period (June to September 2004) when closed irrigation and NPWT were combined were excluded from the analysis. Both groups had comparable demographic and perioperative characteristics, however, the NPWT arm had an insignificant trend towards advanced age, higher logistic EUROSCORE, more complex primary cardiac surgery. No difference in the rate of causative agent was found, with SA and CONS identified in almost 70% of cases. Escherichia coli (5.8%) and Pseudomonas species (7.2%) as leading Gram negative strains were cultivated. The time to presentation of DSWI was insignificant between groups (17.5±15.0 vs. 13.8±16.3, p=0.55) as well as readmission for late clinical presentation of DSWI (38.6% vs. 50%, p=0.12). Although the overall length of DSWI therapy was comparable (14.3±11.9 vs. 14.9±7.9 days, p=0.82), NPWT required more dressing changes (5.4±2.3 vs. 1.8±1.2, p<0.001), but was associated with substantially lower failure of primary therapy (5.1 vs. 39.2%, p<0.01) with closed chest irrigation. In-ICU stay was significantly shorter in the NPWT group (209.6±331.3 vs. 516.1±449.5 hours, p<0.001), nevertheless, shortened in-hospital stay (40.2±16.3 vs. 48.8±29.2 days, p=0.16) was insignificant in this group. Addressing mortality, 30-day and 1-year mortality was considerably lower in the NPWT arm (3.9 vs. 21.4%, p<0.05, 15.8 vs. 39.2%, p<0.05, respectively). A Kaplan-Meier 1 year-survival analysis is shown in Figure 2. The risk of major bleeding complications was comparable between groups, with 2 patients (3.6%) from the closed chest irrigation group having erosion of venous bypass graft and right ventricle (RV), and 3 patients (3.9%) from the NPWT group, including 1 debridement-related and 2 spontaneous injuries of the RV. Employment of local and advancement flaps for covering of residual defects was higher in the NPWT groups (65.7 vs. 17.8%, p<0.01). Our experience showed that NPWT is effective in the treatment of DSWI, compared with closed chest irrigation, leading to lower failure of primary therapy, ICU stay, and better short- and mid-survival of patients. We did not prove NPWT influenced length of in-hospital stay or risk of major bleeding, however, residual defects required more complex approach to assure sternal stability and covering defects [119,130].

Figure 1.

The first-line application protocol of NPWT for treatment of DSWI

Figure 2.

1-year Kaplan-Meier survival analysis comparing NPWT with conventional therapy (CONV)

9.2. Sternal stabilization and management of residual bone defects

Non-complicated sternal dehiscence following DSWI that is not associated with considerable bone loss can be stabilized with transverse titanium plates (Titanium Sternal Fixation system™, Synthes, Switzerland) at our department. Plates are applied on the anterior surface of the ribcage to achieve sufficient stability of the chest wall while minimizing the risk of an iatrogenic injury to the heart. From January 2008 to September 2012 we performed 31 sternal wall reconstructions using the Titanium Sternal Fixation system™. In four cases, osteosynthesis was applied to treat a sterile mechanical dehiscence of the median sternotomy, while 27 other chest osteosyntheses were performed after DSWI when wound bed decontamination was achieved with NPWT. In the postoperative period, 2 patients (7.4%) needed to be operatively revised due to bleeding from pectoral flap advancement; in 3 cases (11.1%) the plates needed to be removed for soft tissue healing complications post-reconstruction. Nevertheless, removal could be postponed until satisfactory healing of the sternal bones was achieved. One patient (3.7%) had to be drained for iatrogenic pneumothorax. We also retrospectively analyzed 21 patients with post-DSWI sternal dehiscence from January 2005 to January 2010, comparing 11 patients with re-cerclage wiring and 10 patients with titanium plate osteosynthesis. DSWI was managed with the same protocol of NPWT prior to reconstruction mentioned above [119]. Plating was accompanied by a lower risk of therapy failure (1% vs. 1.85%), shorter in-hospital stay (22 vs. 59%), and reduction in costs ((€8,243 vs. €33,365) (unpublished data).

In cases of minor sternal bone loss, we use an autologous bone graft harvested from the patient ´s own iliac crest. The graft is preferably prepared as bi-cortical. There is a limit to the extent of bone tissue that can be solved through this method. Fixation of the bone graft and chest stabilization is done in the manner described above. From 2009 to 2012 we used this method in 2 patients. In both cases the wounds healed successfully and the sternal wall regained full stability. Both sternal defects represented partial loss of bone tissue from 6 to 8 cm in length.

Based on this experience, we decided to apply a novel approach for the treatment of massive bone loss after DSWI, by supplying the bone defect with an allogenous bone graft. It allows treating large sternal defects in the same way as a total or near-total sternectomy and fixed properly with titanium plate system ensures chest cage stability. An allogenous bone transplant doesn´t contain any vital bone marrow cells, which eliminates difficulties in immuno-genetic acceptance of the graft by a patient; it represents a biological tissue transfer, which even under conditions of maximum precautions represents a minor risk for transmission of viral or bacterial infections. An allogenous graft must meet legislative criteria from the Czech Republic and the European Association of Tissue Banks [161,162]. Prior to graft harvesting, each donor is cross-checked for registration within the National Registry for organ donation refusal. All deceased donors treated for infectious disease, sepsis, malignant tumors, or systemic and autoimmune diseases at the time of death are withdrawn from the donor list. Donor blood serum samples are tested for antibodies and HIV types 1 and 2, hepatitis B surface antigen (HbsAg), hepatitis C antibodies (anti-HCV), and HTLV I and II antibodies. Harvest of a sternal bone graft is performed under strictly sterile conditions by a team from the National Tissue Center in Brno. The graft is harvested under sterile conditions and stored in the freezer at −80°C. Prior to its clinical use, the graft is thawed at 4-6°C for 12 hours, soaked with a 1% gentamicin solution, prepared for its final shape, and stored in the freezer again at −80°C. If bacterial sampling is negative, the graft is thawed for 12 hours before transplantation, and submerged in a bath with 1% neomycin solution immediately before surgery.

Inherent surgical technique is modified by a more aggressive debridement of residual chest bone or ribs (1-2 cm safety line). Afterwards, the bone graft is adjusted to the size of the bone defect and fixed with plates anchored by self-cutting or self-drilling cortical screws. An uneven surface and tiny bone deficiency can be filled in with a spongy bone which is prepared from another graft provided by the tissue bank (femoral or tibial graft source). Residual soft tissue defect is covered with monolateral or bilateral pectoral muscle flap transfer. Within the postoperative period, it is strongly recommended to avoid excessive coughing or any rough mechanical strain on the sternal wall. Intravenous antibiotics are administered for at least three weeks after the reconstruction. Between January 2010 and September 2012, we performed six reconstructions of the sternal wall using an allogenous bone graft. We used a cadaveric sternum in four cases (Figure 3), and due to a lack of allografts, we had to use a calva bone in one patient (Figure 4) and a split femoral diaphysis in one patient. Successful healing after the reconstruction was achieved in five cases (83%), while one patient required additional treatment for partial skin necrosis. One obese female experienced flap failure and died from multiple organ failure. Follow-up of the other patients at 3, 6 and 12 months after reconstruction proved stability of the chest wall. A radio-isotope scan using technetium as a tracer of autologous leukocytes (Technetium-HMPAO) carried out at 3, 6 and 12 months after the reconstruction showed a high level of healing activity within the area of the allogenous bone implant, and further chest wall stability with allograft union was confirmed through 3D-CT evaluation done 5 to 7 months after the reconstruction (unpublished data).

Figure 3.

Cadaveric sternal allograft and its use for large residual bone defect

Figure 4.

Cadaveric calva bone allograft in large bone defect repair and CT reconstruction showing the bone re-union

9.3. Reconstruction of residual soft tissue defects

In a group of 76 consecutive patients primarily treated with NPWT for DSWI from September 2004 to September 2011, 19 residual defects (25%) were closed by direct suture, and 57 patients (75%) underwent flap transfer to achieve reliable tension-free suture. All but 2 patients (2.7 %) underwent sternal stabilization with re-cerclage (61.8%) or transverse plates with or without bone graft (35.5%). Local fasciocutaneous advancement was used in 12 patients (21.1%), bilateral pectoralis advancement flap in 35 patients (61.2%), monolateral pectoralis flap with V-Y skin island in 7 patients (12.3%), bipedicled pectoral and rectus abdominis flap in 1 patient (1.7%), and vertical rectus abdominis flap in 2 patients (3.5%). We faced 2 flap failures (3.5%) and one whole monolateral pectoralis flap with V-Y skin island was lost due to vascular pedicle thrombosis, with 50% of the mass of the VRAM flap needing to be removed for flap necrosis. Minor healing complications requiring further local wound care were noted in 15 cases (26.3%). While the bilateral pectoralis advancement flap is a technique used by cardiac surgeons, other flaps used for covering larger residual soft tissue defects are utilized by plastic surgeon. The pectoral major flap with V-Y skin island is the first choice (Figure 5). When the defect is wide and deep, or in a female patient with large breasts, the VRAM pedicled flap is considered. If these two options fail or are not accessible, the latissimus dorsi pedicled flap is the next choice, and as a last resort, the microsurgical transfer is taken into account.

Figure 5.

Technique of unilateral pectoral muscle flap advancement with V-Y skin island


10. Conclusion

DSWI remains a potentially fatal complication of cardiac surgery. Even though risk factors for development of DSWI have been identified, few are modifiable. Tight perioperative glycemic control, proper surgical technique, skeletonization of IMA grafts particularly in diabetics, and primary stable sternal approximation for high risk patients including diabetics, obese, immunosuppressed or those with COPD seem to reduce the risk of DSWI. Thanks to the unique combination of closed and open chest treatment, NPWT positively influences the survival of DSWI patients even at long-term follow-up in comparison with conventional therapy. Transverse titanium plates alone or with auto- or allograft bone allows chest cage stability irrespective to the bone mass loss. Better quality of life and lower extent of soft tissue defect might be promising for these patients who faced sternal instability and considerable flap-related morbidity some/few years ago. Plastic surgeons should be included in team planning post-DSWI sternotomy wound closure, not only called when previous closure attempt failed or residual defect seems to be extent.


  1. 1. DaltonM. LConnallyS. RSealyW. CJulian’s reintroduction of Milton’s operation. Ann Thorac Surg 199253532533
  2. 2. MiltonHMediastinal surgery. Lancet 189718725
  3. 3. JulianO. CLopez-belioMDyeW. SJavidHGroveW. JThe median sternal incision in intracardiac surgery with extracorporeal circulation: a general evaluation of its use in heart surgery. Surgery 19574275361
  4. 4. BalaguerJ. MUmakanthanRLeaccheMByrneJ. GMinimally invasive cardiac surgery. Curr Probl Surg. 20124952949
  5. 5. MangramA. JHoranT. CPearsonM. LSilverL. CJarvisW. RThe hospital infection control practise advisory committee. Guidelines for prevention of surgical site infection. Infect Control Hosp Epidemiol 20022024778
  6. 6. LoopF. DLytleB. WCosgroveD. Met alMaxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 19904917987
  7. 7. MilanoC. AKeslerKArchibaldNSextonD. JJonesR. HMediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. Circulation 199592224551
  8. 8. BraxtonJ. HMarrin CAS, McGrath PD, et al. Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg 20007020047
  9. 9. EklundA. MLyytikainenOKlemetsPet alMediastinitis after more than 10,000 cardiac surgical procedures. Ann Thorac Surg 20068217849
  10. 10. The Parisian Mediastinitis Study GroupRisk factors for deep sternal wound infection after sternotomy: a prospective, multicenter study. The Journal of Thoracic and Cardiovascular Surgery 199611112001207
  11. 11. HollenbeakC. SMurphyD. MKoenigSWoodwardR. SDunaganW. CFraserV. JThe clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000118397402
  12. 12. FilsoufiFCastilloJ. GRahmanianP. Bet alEpidemiology of deep sternal wound infection in cardiac surgery. J Cardiothorac Vasc Anesth 20092348894
  13. 13. Tang GHL, Maganti M, Weisel RD, Borger MA. Prevention and management of deep sternal wound infection. Semin Thorac Cardiovasc Surg 200416629
  14. 14. ToumpoulisI. KAnagnostopoulosC. EDerose JJ Jr, Swistel DG. The impact of deep sternal wound infection on long-term survival after coronary artery bypass grafting. Chest 200512746471
  15. 15. RisnesIAbdelnoorMAlmdahlS. MSvennevigJ. LMediastinitis after coronary artery bypass grafting risk factors and long-term survival. Ann Thorac Surg 201089150210
  16. 16. CrabtreeT. DCoddJ. EFraserV. JBaileyM. SOlsenM. ADamiano RJ Jr. Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center. Semin Thorac Cardiovasc Surg. 200420041653
  17. 17. Fowler VG JrO’Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation. 200;112(9 Suppl):I35865
  18. 18. SjögrenJMalmsjöMGustafssonRIngemanssonRPoststernotomy mediastinitis: a review of conventional surgical treatments, vacuum-assisted closure therapy and presentation of the Lund University Hospital mediastinitis algorithm.Eur J Cardiothorac Surg 200630898905
  19. 19. MatrosEArankiS. FBayerL. Ret alReduction in incidence of deep sternal wound infections: random or real? J Thorac Cardiovasc Surg 20101396805
  20. 20. De FeoMVicchioMSantèPCerasuoloFNappiGEvolution in the treatment of mediastinitis: single-center experience. Asian Cardiovasc Thorac Ann. 2011193943
  21. 21. UptonARobertsS. AMilsomPMorrisA. JStaphylococcal post- sternotomy mediastinitis: five year audit. ANZ J Surg. 200575198203
  22. 22. SachithanandanANanjaiahPNightingalePet alDeep sternal wound infection requiring revision surgery: impact on mid-term survival following cardiac surgery. Eur J Cardiothorac Surg 2008336738
  23. 23. PritisanacAGulbinsHRosendahlUEnnkerJOutcome of heart surgery procedures in octogenarians: is age really not an issue? Expert Rev Cardiovasc Ther 2007
  24. 24. PrabhakarGHaanC. KPetersonE. DCoombsL. PCruzzavalaJ. LMurrayC. FThe risks of moderate and extreme obesity for coronary artery bypass grafting outcomes: A study from the Society of Thoracic Surgeons’ database. Ann Thorac Surg 200274112531
  25. 25. FurnaryA. PZerrK. JGrunkemeierG. LStarrAContinuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 19996735260
  26. 26. HalkosM. EPuskasJ. DLattoufO. Met alElevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 200813663140
  27. 27. ToumpoulisI. KTheakosNDunningJDoes bilateral internal thoracic artery harvest increase the risk of mediastinitis? Interact Cardiovasc Thorac Surg 2007678791
  28. 28. De PaulisRDe NotarisSScaffaRet alThe effect of bilateral internal thoracic artery harvesting on superficial and deep sternal infection: the role of skeletonization. J Thorac Cardiovasc Surg 200512953643
  29. 29. CurtisJ. JClarkN. CMckenneyC. Aet alTracheostomy: a risk factor for mediastinitis after cardiac operation. Annals of Thoracic Surgery 200172731734
  30. 30. RahmanianP. BAdamsD. HCastilloJ. Get alTracheostomy is not a risk factor for deep sternal wound infection after cardiac surgery. Annals of Thoracic Surgery 20078419841991
  31. 31. HubnerNReesWSeufertKet alPercutaneous dilatational tracheostomy done early after cardiac surgery-outcome and incidence of mediastinitis. The Thoracic and Cardiovascular Surgeon 1998468992
  32. 32. DiehlJ. LEl AtrousSTouchardDet alChanges in the work of breathing induced by tracheotomy in ventilator-dependent patients. American Journal of Respiratory and Critical Care Medicine 1999159383388
  33. 33. BanburyM. KBrizzioM. ERajeswaranJet alTransfusion increases the risk of postoperative infection after cardiovascular surgery. Journal of the American College of Surgeons 2006202131138
  34. 34. GardlundBBitkoverCVaageJPostoperative mediastinitis in cardiac surgery microbiology and pathogenesis. Eur J Cardiothorac Surg 20022182530
  35. 35. Mekontso-dessapAKirschMBrun-buissonCLoisanceDPoststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistent and methicillin-susceptible cases. Clin Infect Dis 20013287783
  36. 36. San Juan R, Chaves F, López Gude MJ, Díaz-Pedroche C, Otero J, Cortina Romero JM, Rufilanchas JJ, Aguado JM.Staphylococcus aureus poststernotomy mediastinitis: description of two distinct acquisition pathways with different potential preventive approaches. J Thorac Cardiovasc Surg. 20071346706
  37. 37. JakobH. GBorneff-lippMBachAet alThe endogenous pathway is a major route for deep sternal wound infection. European Journal of Cardio-Thoracic Surgery 200017154160
  38. 38. KluytmansJ. AMoutonJ. WIjzermanE. Pet alNasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. The Journal of Infectious Diseases 1995171216219
  39. 39. Von EiffCBeckerKMachkaKStammerHPetersGNasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 20013441116
  40. 40. San Juan R, Aguado JM, López MJ, et al. Accuracy of blood culture for early diagnosis of mediastinitis in febrile patients after cardiac surgery. Eur J Clin Microbiol Infect Dis. 2005200524182
  41. 41. TegnellAArenCOhmanLCoagulase-negative staphylococi and sternal infections after cardiac operation. Ann Thorac Surg 20006911049
  42. 42. Mekontso Dessap A, Vivier E, Girou E, Brun-Buisson C, Kirsch M.Effect of time to onset on clinical features and prognosis of post-sternotomy mediastinitis. Clin Microbiol Infect 2011172929
  43. 43. JonkersDElenbaasTTerportenPet alPrevalence of 90 days postoperative wound infections after cardiac surgery. European Journal of Cardio-Thoracic Surgery 20032397102
  44. 44. Mekontso-dessapAKirschMBrun-buissonCLoisanceDPoststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis. 20013287783
  45. 45. MauermannW. JSampathkumarPSternal wound infection. Best Practice & Research Clinical Anaesthesiology 200822423436
  46. 46. BaillotRCloutierDMontalinLet alImpact of deep sternal wound infection management with vacuum-assisted closure therapy followed by sternal osteosynthesis: a 15-year review of 23,499 sternotomies. Eur J Cardiothorac Surg 2010378807
  47. 47. SpeirA. MKasirajanVBarnettS. DFonnerEJr. Additive costs of postoperative complications for isolated coronary artery bypass grafting patients in Virginia. Ann Thorac Surg 200988406
  48. 48. De FeoMRenzulliAIsmenoGGregorioRDella Corte A, Utili R, et al. Variables predicting adverse outcome in patients with deep sternal wound infection. Ann Thorac Surg 200171324331
  49. 49. GrafKOttEVonbergR. PKuehnCHaverichAChabernyI. FEconomic aspects of deep sternal wound infections. Eur J Cardiothorac Surg 2010378936
  50. 50. EnnkerI. CKojciciBEnnkerJVogtPMelichercikJExamination of the opportunity costs and turnover situation in patients with deep sternal infections. Zentralbl Chir 201213725761
  51. 51. MoidlRFleckTGiovanoliPGrabenwögerMWolnerECost effectiveness of V.A.C. therapy after post-sternotomy mediastinitis. Zentralbl Chir 2006S18990
  52. 52. MokhtariASjögrenJNilssonJGustafssonRMalmsjöMIngemanssonRThe cost of vacuum-assisted closure therapy in treatment of deep sternal wound infection. Scand Cardiovasc J 2008428589
  53. 53. AtkinsZ. BWolfeGSternal Wound Complications Following Cardiac Surgery. In: Cuneyt N. (ed). Special topics in cardiac surgery. Rijeka, InTech; 284308
  54. 54. LazarH. LChipkinS. RFitzgeraldC. ABaoYCabralHApsteinC. STight glycemiccontrol in diabetic coronary artery bypass graft patients improves perioperativeoutcomes and decreases recurrent ischemic events. Circulation 20041091497502
  55. 55. GandhiG. YNuttallG. AAbelM. DMullanyC. JSchaffH. VOBrienP. CJohnsonM. GWilliamsA. RCutshallS. MMundyL. MRizzaR. AMcmahonMM. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 200;14623343
  56. 56. BratzlerD. WHouckP. MRichardsCSteeleLet alUse of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 200514017482
  57. 57. FinkelsteinRRabinoGMashiahTet alVancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. The Journal of Thoracicand Cardiovascular Surgery 2002123326332
  58. 58. BolonM. KMorloteMWeberS. Get alGlycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clinical Infectious Diseases 20043813571363
  59. 59. FribergOSvedjeholmRSoderquistBGranfeldtHVikerforsTKallmanJLocal gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg 20057915361
  60. 60. FribergODahlinL. GKällmanJKihlströmESöderquistBSvedjeholmRCollagen-gentamicin implant for prevention of sternal wound infection; long-term follow-up of effectiveness.Interact Cardiovasc Thorac Surg. 200994548
  61. 61. Bennett-guerreroEFerguson TB Jr, Lin M, Garg J, Mark DB, Scavo VA Jr et al. SWIPE-1 Trial Group. Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. J Am Med Assoc 201030475562
  62. 62. MavrosM. NMitsikostasP. KAlexiouV. GPeppasGFalagasM. EGentamicin collagen sponges for the prevention of sternal wound infection: A meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg. 2012144123540
  63. 63. KaiserA. BKernodleD. SBargN. Let alInfluence of preoperative showers on staphylococcal skin colonization: a comparative trial of antiseptic skin cleansers. Annals of Thoracic Surgery 1988453538
  64. 64. Byrne DNA, Cuschieri A. The value of whole body disinfection in the prevention of post-operative wound infection in clean and potentially contaminated surgery. Surgical Research Communications 1992124352
  65. 65. PerlT. MGolubJ. ENew approaches to reduce Staphylococcus aureus nosocomial infection rates:treating S. aureus nasal carriage. Annals of Pharmacotherapy 1998S716
  66. 66. CimochowskiG. EHarostockM. DBrownRet alIntranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Annals of Thoracic Surgery 20017115721578
  67. 67. KonvalinkaAErrettLFongI. WImpact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect. 2006641628
  68. 68. GrafKSohrDHaverichAKühnCGastmeierPChabernyI. FDecrease of deep sternal surgical site infection rates after cardiac surgery by a comprehensive infection control program. Interact Cardiovasc Thorac Surg. 200992826
  69. 69. SasoSJamesDVechtJ. AKidherEKokotsakisJMalinovskiVRaoCDarziAAndersonJ. RAthanasiouTEffect of skeletonization of the internal thoracic artery for coronary revascularization on the incidence of sternal wound infection. Ann Thorac Surg 20108966170
  70. 70. HiroseHAmanoATakanashiSTakahashiASkeletonized bilateral internal mammary artery grafting for patients with diabetes. Interact Cardiovasc Thorac Surg 2003228792
  71. 71. Baskett RJF, MacDougall CE, Ross DB. Is mediastinitis a preventable complication? A 10-year review. Ann Thorac Surg 1999674625
  72. 72. RobicsekFDaughertyH. KCookJ. WThe prevention and treatment of sternum separartion following open-heart surgery J Thorac Cardiovasc Surg 197773267268
  73. 73. SharmaRPuriDPanigrahiB. PVirdiI. SA modified parasternal wire technique for prevention and treatment of sternal dehiscence Ann Thorac Surg 200477210213
  74. 74. FribergÖDahlinL. GSöderquistBKällmanJSvedjeholmRInfluence of more than six sternal fixation wires on the incidence of deep sternal wound infection Thorac Cardiovasc Surg 200654468473
  75. 75. SchimmerCReentsWBernederSet alPrevention of sternal dehiscence and infection in high-risk patients: a prospective randomized multicenter trial. Ann Thorac Surg 2008861897904
  76. 76. PlassAEmmertM. YPilslMSalzbergS. PGenoniMFalkVGrunenfelderJSternal plate closure: indications, surgical procedure and follow-up. Thorac Cardiovasc Surg 201159303
  77. 77. RamanJLehmannSZehrKet alSternal Closure With Rigid Plate Fixation Versus Wire Closure: A Randomized Controlled Multicenter Trial. Ann Thorac Surg. 2012doi:pii:S0003-4975(12)01863-2. 0.1016/j.athoracsur.2012.07.085. [Epub ahead of print]
  78. 78. NegriAManfrediJTerriniARodellaGBisleriGEl QuarraSMunerettoCProspective evaluation of a new sternal closure method with thermoreactive clips. Eur J Cardiothorac Surg 2002225715
  79. 79. SnyderC. WGrahamL. AByersR. EHolmanW. LPrimary sternal plating to prevent sternal wound complications after cardiac surgery: early experience and patterns of failure. Interact CardioVasc Thorac Surg 20099763766
  80. 80. Bennett-guerreroEPhillips-buteBWaweruP. MGacaJ. GSpannJ. CMilanoC. APilot study of sternal plating for primary closure of the sternum in cardiac surgical patients. Innovations. 201163828
  81. 81.
  82. 82. StannardJ. PAtkinsB. ZOMalleyDSinghHBernsteinBFaheyMMasdenDAttingerCE. Use of negative pressure therapy on closed surgical incisions: a case series. Ostomy Wound Management 2009555866
  83. 83. WackenforsASjögrenJGustafssonRAlgotssonLIngemanssonRMalmsjöMEffects of vacuum-assisted closure therapy on inguinal wound edge microvascular blood flow. Wound Repair Regen 2004126006
  84. 84. ColliAFirst experience with a new negative pressure incision management system on surgical incisions after cardiac surgery in high risk patients. Journal of Cardiothoracic Surgery 2011
  85. 85. AtkinsB. ZWootenM. KKistlerJHurleyKHughesG. CWolfe WG: Does negative pressure wound therapy have a role in preventing poststernotomy wound complications? Surg Innov 2009
  86. 86. RobicsekFPostoperative Sterno-mediastinitis. Am Surg 200066184192
  87. 87. SarrM. GGottV. LTownsendT. RMediastinal infection after cardiac surgery. Ann Thorac Surg 1984
  88. 88. ShumackerH. BMandelbaumIContinuous antibiotic irrigation in the treatment of infection. Arch Surg 1963
  89. 89. MerrillW. HAkhterS. AWolfR. KSchneebergerE. WFlege JB Jr. Simplified treatment of postoperative mediastinitis..Ann Thorac Surg. 20047860812
  90. 90. .PonceletA. JLengeleBDelaereBet alAlgorithm for primary closure in sternal wound infection: a single institution 10-year experience. Eur J Cardiothorac Surg. 2008332328
  91. 91. KirschMMekontso-dessapAHouëlRGiroudEHillionM. LLoisanceD. YClosed drainage using redon catheters for poststernotomy mediastinitis: results and risk factors for adverse outcome.. Ann Thorac Surg. 20017115806
  92. 92. LeviNOlsenP. SPrimary closure of deep sternal wound infection following open heart surgery: a safe operation? J Cardiovasc Surg (Torino). 2000Apr;4122415
  93. 93. LeeA. BSchimertGShaktinSet alTotal excision of the sternum and thoracic pedicle transposition of the greater omentum; useful stratagems in managing severe mediastinal infection following open heart surgery. Surgery 1976804336
  94. 94. JurkiewiczM. JBostwickJHesterT. Ret alInfected median sternotomy wound: successful treatment by muscle flaps. Ann Surg 1980
  95. 95. JonesGJurkiewiczM. JBostwick, et alManagement of the infected median sternotomy wound with muscle flaps. Ann Surg 199722576678
  96. 96. BrandtCAlvarezJ. MFirst-line treatment of deep sternal infection by a plastic surgical approach: superior results compared with conventional cardiac surgical orthodoxy. Plast Reconstr Surg. 200210922317
  97. 97. Wong CHK, Senewiratne S, Garlick G, Mullany D. Two-stage management of sternal wound infection using bilateral pectoralis major advancement flap. Eur J Cardiothorac Surg 200630148152
  98. 98. MilanoC. AGeorgiadeGMuhlbaierL. HSmithP. KWolfeW. GComparison of omental and pectoralis flaps for poststernotomy mediastinitis. Ann Thorac Surg 19996737781
  99. 99. El OakleyR. MWrightJ. EPostoperative mediastinitis: classification and management. Ann Thorac Surg 19966110306
  100. 100. MolinaEPrimary closure for infected dehiscence of the sternum. Ann Thorac Surg 19935545963
  101. 101. ScullyH. ELeclercYMartinR. Det alComparison between antibiotic irrigation and mobilization of pectoral muscle flaps in treatment of deep sternal infection. J Thorac Cardiovasc Surg 19859052331
  102. 102. RandR. PCochranR. PAzizSHoferB. OAllenM. DVerrierE. Det alProspective trial of catheter irrigation and muscle flaps for sternal wound infection. Ann Thorac Surg 19986510461049
  103. 103. RingelmanP. RVanderK. CCameronDBumgartnerW. AMansonP. NLong-term results of flap reconstruction in median sternotomy wound infection. Plast Reconstr Surg 199493120814
  104. 104. PairoleroP. CArnoldP. CManagement of recalcitrant median sternotomy wounds. J Thorac Cardiovasc Surg 19848835764
  105. 105. LeviNOlsenP. SPrimary closure of deep sternal wound infection following open heart surgery: a safe operation? J Cardiovasc Surg (Torino). 2000412415
  106. 106. NahaiFRandR. PHesterT. Ret alPrimary treatment of the infected sternotomy wound with muscle flaps: a review of 211 consecutive cases. Plast Reconstr Surg 198984434441
  107. 107. KutsalAIbrisimECatavZet alMediastinitis after open heart surgery. Analysis of risk factors and management. J Cardiovasc Surg (Torino) 1991323841
  108. 108. Van WingerdenJ. JCoretM. EVan NieuwenhovenC. ATottéE. RThe laparoscopically harvested omental flap for deep sternal wound infection. Eur J Cardiothorac Surg 2010378792
  109. 109. AtkinsB. ZOnaitisM. WHutchesonK. AKayeKPetersenR. PWolfeW. GDoes method of sternal repair influence long-term outcome of postoperative mediastinitis? Am J Surg. 20112025657
  110. 110. ChristianMThe role of hyperbaric oxygen therapy in the treatment of sternal wound infectionEur J Cardiothorac Surg 200630153159
  111. 111. SiondalskiPKeitaLSickoZZelechowskiPJaworskiLRogowskiJSurgical treatment and adjunct hyperbaric therapy to improve healing of wound infection complications after sterno-mediastinitis. Pneumonol Alergol Pol 2003711216
  112. 112. ObdeijnM. CDe LangeM. YLichtendahlD. HDe BoerW. JVacuum-assisted closure in the treatment of poststernotomy mediastinitis. Ann Thorac Surg 199968235860
  113. 113. CatarinoP. AChamberlainM. HWrightN. CBlackECampbellKRobsonDPillaiR. GHigh-pressure suction drainage via a polyurethane foam in the management of poststernotomy mediastinitis. Ann Thorac Surg 20007018915
  114. 114. GustafssonR. ISjögrenJIngemanssonRDeep sternal wound infection: a sternal-sparing technique with vacuum-assisted closure therapy. Ann Thorac Surg. 200376204853
  115. 115. FleckT. MFleckMMoidlRet alThe vacuum-assisted closure system for the treatment of deep sternal wound infections after cardiac surgery. Ann Thorac Surg 2002741596600
  116. 116. SjögrenJGustafssonRNilssonJLindstedtSNozohoorSIngemanssonRNegative-pressure wound therapy following cardiac surgery: bleeding complications and 30-day mortality in 176 patients with deep sternal wound infection. Interact Cardiovasc Thorac Surg 20111211720
  117. 117. FleckTMoidlRGiovanoliPet alA conclusion from the first 125 patients treated with the vacuum assisted closure system for postoperative sternal wound infection. Interact Cardiovasc Thorac Surg. 200651458
  118. 118. EnnkerI. CMalkocAPietrowskiDVogtP. MEnnkerJAlbertAThe concept of negative pressure wound therapy (NPWT) after poststernotomy mediastinitis--a single center experience with 54 patients. J Cardiothorac Surg. 2009Jan 12;4:5.
  119. 119. ŠimekMKalábMMolitorMet alTopical negative pressure in the treatment of deep sternal infection following cardiac surgery: 5-year results of first-line application protocol. The EWMA Journal 2011113841
  120. 120. GustafssonRJohnssonPAlgotssonLBlomquistSIngemanssonRVacuum-assisted closure therapy guided by C-reactive protein level in patients with deep sternal wound infection. J Thorac Cardiovasc Surg 2002123895900
  121. 121. BergH. FBrands WGB, Geldrop van TR, Kluytmans-VandenBergh MFQ, Kluytmans JAJW. Comparison between closed drainage techniques for the treatment of postoperative mediastinitis. Ann Thorac Surg 200070924929
  122. 122. DossMMartensSWoodJ. PWolffJ. DBaierCMoritz. Vacuum-assisted suction drainage versus conventional treatment in the management of poststernotomy osteomyelitis Eur J Cardiothorac Surg 200222934938
  123. 123. SongD. HWuL. CLohmanR. FGottliebL. JFranczykMVacuum-assisted closure for the treatment of sternal wounds: the bridge between debridement and definitive closure. Plast Reconstr Surg 20031119297
  124. 124. LuckrazHMurphyFBryantSCharmanSRitchieAVacuum-assisted closure as a treatment modality for infections after cardiac surgery J Thorac Cardiovasc Surg 2003125301305
  125. 125. FuchsUZittermannAStuettenBGroeningAMinamiKKoeferRClinical outcome of patients with deep sternal infection managed by vacuum-assisted closure compared to conventional therapy with open packing: A retrospective analysis. Ann Thorac Surg 20057952631
  126. 126. SjögrenJGustafssonRNilssonJMalmsjöMIngemanssonRClinical outcome after poststernotomy mediastinitis: vacuum-assisted closure versus conventional treatment. Ann Thorac Surg. 200579204955
  127. 127. ImmerF. FDurrerMMühlemannK. SErniDGahlBCarrelT. PDeep sternal wound infection after cardiac surgery: modality of treatment and outcome. Ann Thorac Surg. 20058095761
  128. 128. SegersPDe JongA. PKloekJ. Jde Mol BAJM. Poststernotomy mediastinitis: comparison of two treatment modalities. Interact Cardiovasc Thorac Surg 20054555560
  129. 129. PetzinaRHoffmannJNavasardyanAet alNegative pressure wound therapy for post-sternotomy mediastinitis reduces mortality rate and sternal re-infection rate compared to conventional treatment.Eur J Cardiothorac Surg 2010381103
  130. 130. SimekMHajekRFlugerIet alSuperiority of topical negative pressure over closed irrigation therapy of deep sternal wound infection in cardiac surgery. J Cardiovasc Surg (Torino) 20125311320
  131. 131. De FeoMDella Corte A, Vicchio M, Pirozzi F, Nappi G, Cotrufo M. Is post-sternotomy mediastinitis still devastating after the advent of negative-pressure wound therapy? Tex Heart Inst J 20113837580
  132. 132. AssmannABoekenUFeindtPSchurrPAkhyariPLichtenbergAVacuum-assisted wound closure is superior to primary rewiring in patients with deep sternal woundinfection. Thorac Cardiovasc Surg 201159259
  133. 133. VosR. JYilmazASonkerUKelderJ. CKloppenburgG. TVacuum-assisted closure of post-sternotomy mediastinitis as compared to open packing. Interact Cardiovasc Thorac Surg. 2012141721
  134. 134. DenizHGokaslanGArslanogluYOzcaliskanOGuzelGYasimAUstunsoyHTreatment outcomes of postoperative mediastinitis in cardiac surgery; negative pressure wound therapy versus conventional treatment. J Cardiothorac Surg 2012
  135. 135. FleckTFleckMNegative pressure wound therapy for the treatment of sternal wound infections after cardiac surgery. Int Wound J 2012doi:j.1742481X.2012.01079.x. [Epub ahead of print]
  136. 136. RajaS. GBergG. AShould vacuum-assisted closure therapy be routinely used for management of deep sternal wound infection after cardiac surgery?Interact CardioVasc Thorac Surg 20076523
  137. 137. SchimmerCSommerS. PBenschMElertOLeyhRManagement of poststernotomy mediastinitis: experience and results of different therapy modalities.Thorac Cardiovasc Surg. 2008562004
  138. 138. DamianiGPinnarelliLSommellaLToccoM. PMarvulliMMagriniPRicciardiWVacuum-assisted closure therapy for patients with infected sternal wounds: a meta-analysis of current evidence. J Plast Reconstr Aesthet Surg 201164111923
  139. 139. De FeoMVicchioMNappiGCotrufoMRole of vacuum in methicillin-resistant deep sternal wound infection.Asian Cardiovasc Thorac Ann. 2010183603
  140. 140. Al-ebrahimK. ESternocutaneous fistulas after cardiac surgery. Ann Thorac Surg 20108917056
  141. 141. GaudreauGCostacheVHoudeCCloutierDMontalinLVoisinePBaillotRRecurrent sternal infection following treatment with negative pressure wound therapy and titanium transverse plate fixation. Eur J Cardiothorac Surg. 20103788892
  142. 142. SteingrímssonSGustafssonRGudbjartssonTMokhtariAIngemanssonRSjögrenJSternocutaneous fistulas after cardiac surgery: incidence and late outcome during a ten-year follow-up. Ann Thorac Surg 20098819105
  143. 143. DarouicheR. OTreatment of infections associated with surgical implants.N Engl J Med 200435014229
  144. 144. Bu-omarYNaikM. JCatarinoP. ARatnatungaCRight ventricular rupture during use of high-pressure suction drainage in the management of poststernotomy mediastinitis. Ann Thorac Surg. 2003
  145. 145. BapatVEl-MuttardiNYoungCVennGRoxburghJExperience with Vacuum-assisted closure of sternal wound infections following cardiac surgery and evaluation of chronic complications associated with its use. J Card Surg. 20082322733
  146. 146. Van WingerdenJ. JSegersPJekelLMajor bleeding during negative pressure wound/V.A.C.®--therapy for postsurgical deep sternal wound infection--a critical appraisal. J Cardiothorac Surg. 201;6:121.
  147. 147. HaywardR. HKorompaiF. LKnightW. LThe open sternotomy wound and risk of acute hemorrhage. J Thorac Cardiovasc Surg 1992103122830
  148. 148. KhoynezhadAAbbasGPalazzoR. SGraverL. MSpontaneous right ventricular disruption following treatment of sternal infection. J Card Surg 200419748
  149. 149. NiclaussLDelayDStumpeFRight ventricular rupture due to recurrent mediastinal infection with a closed chest. Interact Cardiovasc Thorac Surg 2010104702
  150. 150. PetzinaRMalmsjöMStammCHetzerRMajor complications during negative pressure wound therapy in poststernotomy mediastinitis after cardiac surgery. J Thorac Cardiovasc Surg.201014011336
  151. 151. MalmsjöMPetzinaRUganderMEngblomHTorbrandCMokhtariAHetzerRArhedenHIngemanssonRPreventing heart injury during negative pressure wound therapy in cardiac surgery: assessment using real-time magnetic resonance imaging. J Thorac Cardiovasc Surg 20091387127
  152. 152. VossBBauernschmittRWillAet alSternal reconstruction with titanium plates in complicated sternal dehiscence. Eur J Cardiothorac Surg 200834139145
  153. 153. GaudreauGCostacheVHoudeCCloutierDMontalinLVoisinePBaillotRRecurrent sternal infection following treatment with negative pressure wound therapy and titanium transverse plate fixation. Eur J Cardiothorac Surg 20103788892
  154. 154. VossBBauernschmittRBrockmannGet alOsteosynthetic thoracic stabilization after complete resection of sternum. Eur J Cardiothorac Surg 200732391393
  155. 155. PiotrowskiJ. AFischerMKlaesWSplittgerberFAutologous bone transplant after sternal resection. J Cardiovasc Surg (Torino) 19963717981
  156. 156. NahabedianM. YRileyL. Hand GreeneP. Set alSternal stabilization using allograft fibula following cardiac transplantation. Plastic Reconstr Surg 200110812848
  157. 157. MarulliGHamadA. MCogliatiEBredaCZuinAReaFAllograft sternochondral replacement after resection of large sternal chondrosarcoma. J Thorac Cardiovasc Surg 2010e6970
  158. 158. Dell’amore A, Cassanelli N, Dolci G, Stella F.An alternative technique for anterior chest wall reconstruction: the sternal allograft transplantation. Interact Cardiovasc ThoracInteract Cardiovasc Thorac Surg. 2012159447
  159. 159. Dell’Amore A, Dolci G, Cassanelli N, Bini A, Stella F.A massive post-sternotomy sternal defect treated by allograft sternal transplantation. J Card Surg 2012275579
  160. 160. KalabMMolitorMKubesovaBLonskyVUse of allogenous bone graft and osteosynthetic stabilization in treatment of massive post-sternotomy defects. Eur J Cardiothorac Surg. 2012Jun;41(6):e1824
  161. 161. Collection of Laws of The Czech RepublicAct 2962008Collegium on Human Tissues and Cells. Prague, 2008.
  162. 162. European Association of Tissue BanksGeneral Standards for Tissue Banking. ÖBIG-Transplant, Vienna, 1995
  163. 163. PerkinsD. JHuntJ. APenningtonD. GSternH. SSecondary sternal repair following median sternotomy using interosseous absorbable sutures and pectoralis major myocutaneous advancement flaps. British J Plast Surg 199649214219
  164. 164. BritoJ. DAssumpcaoC. RMuradHJazbikA. PSa MPL, Bastos ES, Giambroni Filho R, Silva RS. One-stage management of infected sternotomy wounds using bilateral pectoralis major myocutaneous advancement flap. Rev Bras Cir Cardiovasc 2009245863
  165. 165. Greig AVH, Geh JLC, Khanduja V, Shibu M.Choice of flap for the management of deep sternal wound infection- an anatomical classification. J Plast Reconstr Aesth Surg. 200760372378
  166. 166. SalgadoC. JMardiniSMamaliA. AOrtizJGonzalesRChenH. CMuscle versus nonmuscle flaps in the reconstructon of chronic osteomyelitis defects. Plast Reconstr Surg, 200611814011411
  167. 167. YazarSLinY. TUlusalA. EWeiF. COutcome comparison between free muscle and free fasciocutaneous flaps for reconstruction of distal third and ankle traumatic opetn tibial fractures. Plast Reconstr Surg, 200611724682475
  168. 168. SerafinDThe Pectoralis Major Muscle Flap. In Serafin D. Atlas of Microsurgical Composite Tissue Tranplantation. W.B.Saunders company, London, 19961996161174
  169. 169. NetscherD. TEladoumikdachiFMchughP. MThornbyJSolteroESternal wound debridement and muscle flap reconstruction: functional implications. Annals of Plast Surg 200351115122
  170. 170. CohenMYanivYWeissJGreifJGurEWertheymEShafirRMedian sternotomy wound complication: the effect of reconstruction on lung function. Annals Plast Surg 1997393643
  171. 171. ArnoldP. GPairoleroP. CChest-wall reconstruction. An account of 500 consecutive patients. Plast Reconstr Surg 199698804810
  172. 172. SkorackiR. JChangD. WReconstruction of the chestwall and thorax. J Surg Oncol 200694455465
  173. 173. AschermanJ. APatelS. MMalhotraS. MSmithC. RManagement of sternla wounds with bilateral pectoralis major myocutaneous advancement flaps in 114 consecutively treated patients: refinements in technique and outcomes analysis. Plast Reconstr Surg 200411467683
  174. 174. HugoN. ESultanM. RAschermanJ. APatsisM. CSmithC. RRoseE. ASingle-stage management of 74 consecutive sternla wound complications with pectoralis major myocutaneous advancement flaps. Plast Reconstr Surg 19949314331441
  175. 175. BrutusJ. PNikolisAPerreaultIHarrisP. GThe unilateralpectoralis major island flap, an efficient and straightforward procedure for reconstruction of full length sternal defects after postoperative mediastinal wound infection. Brit J Plast Surg 200457803805
  176. 176. ChouETaiYChenHChenKSimple and reliable way in sternum wound coverage-tripedicle pectoralis major musculocutaneous flap. Microsurgery. 2008284416
  177. 177. MajureJ. AAlbinR. EODonnellR. SArganeseTJ. Reconstruction of the infected median sternotomy wound. Ann Thorac Surg 198642912
  178. 178. MolitorMSimekMLonskýVKalábMVeselýJZálešákBPectoral muscle flap with v-y skin paddle for covering sternal defects. Ann Thorac Surg. 2012e1313
  179. 179. HallockG. GThe breast musculocutaneous flap for complete coverage of the median sternotomy wound. Plast Reconstr Surg 2003112199203
  180. 180. NahaiFMoralesLBoneD. KBotswickJPectoralis Major Muscle Turnover Flaps for Closure of the infected Sternotomy Wound with Preservation of Form and Function. Plast Reconstr Surg 198270471474
  181. 181. SpiessA. MBalakrishnanC. HGurselEFascial release of the pectoralis major:a technique used in pectoralis major muscle closure of the mediastinum in cases of mediastinitis. Plast Reconstr Surg. 20071195737
  182. 182. SerafinDThe Pectoralis Major Muscle Flap. In Serafin D. Atlas of Microsurgical Composite Tissue Tranplantation. W.B.Saunders company, London, 19961996221247
  183. 183. SkorackiR. JChangD. WReconstruction of the chestwall and thorax. J Surg Oncol. 20069445565Review.
  184. 184. AcinapuraA. JGodfreyNRomitaMCunninghamJAdamsP. XJacobowitzI. SRoseD. MNealonTSurgical management of infected median sternotomy:Closed irrigation vs muscle flaps. J Cardiovasc. Surg 198526443446
  185. 185. FordT. DRectus abdominis myocutaneous flap used to close a median sternotomy chest defect. S Afr Med J 198568115116
  186. 186. SolomonM. PGranickM. SBipedicle muscle flaps in sternal wound repair. Plast Reconstr Surg. 19981013566
  187. 187. Laitung JKG, Peck F. Shoulder function following the loss of the latissimus dorsi muscle. British J Plast Surg 198538375379
  188. 188. DejesusR. APalettaJ. DDabbR. WReconstruction of the median sternotomy sound dehiscence using the latissimus dorsi myocutaneous flap. J Cardiovasc Surg 200142359564
  189. 189. FansaHHandsteinSSchneiderWTreatment of infected median sternotomy wounds with a myocutaneous latissimus dorsi muscle flap. Scand Cardiovasc J 1998323339
  190. 190. RoshanAKotwalARiazMStanley PRW. Sternal wound dehiscence complicated by macromastia: report of two cases with discussion of literature. J Plast Reconstr Aesth Surg 2009e362e364.
  191. 191. CopelandMSenkowskiCErginAet alMacromastia as a factor in sternal wound dehiscence following cardiac surgery:management combining chest wall reconstruction and reduction mammaplasty. J Card Surg 19927275278
  192. 192. FontaineSDevosSGoldschmidtDReduction mammoplasty combined with pectoralis major muscle flaps for median sternotomy wound closure. Br J Plats Surg 199649220222
  193. 193. UygurFSeverCUlkurECelikozBReconstruction of large post-sternotomy wound with bilateral V-Y fasciocutaneous advancement flaps. Ann Thorac Surg 20088610121015
  194. 194. RoshanAKotwalARiazMStanley PRW. Sternal wound dehiscence complicated by macromastia: report of two cases with discussion of literature. J Plast Reconstr Aesth Surg 2009e362e364.
  195. 195. WüringerEMaderNPoschEHolleJNerve and vessel supplying ligamentous suspension of the mammary gland. Plast Reconstr Surg 199810114861493
  196. 196. HamdiMDanceyAThe septum-based therapeutic mammaplasty technique for management of sternal defects. Plast Reconstr Surg 2010569573
  197. 197. HughesK. CHenryM. JTurnerJMandersE. KDesign of the cyclops flap for chest-wall reconstruction. Plast Reconstr Surg 1997100114651
  198. 198. AydinAGüvenEKeklikBBasaranKÖzkanBReconstruction of the Chest Wall Defects with Mammary Dermoglandular Advancement Flaps in Female Complicated Cases. Trakya Univ Tip Fak Derg 200926130133
  199. 199. YasuuraKOkamotoHMoritaSOgawaYSawazakiMSekiAMasumotoHMatsuuraAMasekiTToriiSResults of omental flap transposition for deep sternal wound infection after cardiovascular surgery. Annals of Surg 1998227455459
  200. 200. MathisenD. JGrilloH. CVlahakesG. Jet alThe omentum in the management of complicated cardiothoracic probleme. J Thorac Cardiovasc Surg 198895677684
  201. 201. WeinzweigNHetmanRTransposition of the greater omentum for recalcitrant median sternotomy wound infection. Annals Plast. Surg 199534471477
  202. 202. AldayE. SGolsdmithH. SSurgical technique for ometal lenghtening based on arterial anatomy. Surg Gynecol Obstet 1972
  203. 203. DasS. KThe size of the human omentum and methods of lenghtening it for transposition. Br J Plast Surg 197629170174
  204. 204. WeinzweigNHetmanRTransposition of the greater omentum for recalcitrant median sternotomy wound infection. Annals Plast. Surg 199534471477
  205. 205. PearlS. NDibbellD. GReconstruction after median sternotomy infection. Surg Gynecol Obstet 19841594752
  206. 206. ColenL. BHuntsmanW. TMorainW. DThe integrated approach to suppurative mediastinitis: rewiring the sternum over transposed omentum. Plast Reconstr Surg 198984936943
  207. 207. HakeliusLFatal complication after use of the greater omentum for reconstruction of the chest wall. Plast Reconstr Surg 1978
  208. 208. AcarturkT. OSwartzW. MLuketichJet alLaparoscopically harvested omental flap for chest wall and intrathoracic reconstruction. Ann Plast Surg 200453210216
  209. 209. BarraganB. AHallodorssonA. OWachtelM. SFrezzaE. ELaparoscopic greater omentum harvesting with split-thickness skin grafting for sternal wound dehiscence. The American Surgeon 200672829832
  210. 210. ReichenbergerM. AHarenbergP. SPelzerMGazyakanERysselGHermannGEngelHArteriovenous loops in microsurgical free tissue transfer in reconstruction of central sternal defects. J Thorac Cardiovasc Surg 201014012831287
  211. 211. EngelHPelzerMSauerbierMHermannGHeitmannCAn innovative treatment concept for free flap reconstruction of komplex central chest wall defects- the cephalic-thoraco-acromial (CTA) loop. Microsurgery 200727481486

Written By

Martin Šimek, Martin Molitor, Martin Kaláb, Patrick Tobbia and Vladimír Lonsky

Submitted: July 9th, 2012 Published: March 13th, 2013